{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 596172, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:50:43Z", "timestamp": 1574311843735}, "reference-count": 35, "publisher": "Springer Science and Business Media LLC", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Res"], "published-print": {"date-parts": [[2009, 8]]}, "DOI": "10.1203/pdr.0b013e3181ac4a30", "type": "journal-article", "created": {"date-parts": [[2009, 7, 15]], "date-time": "2009-07-15T07:28:31Z", "timestamp": 1247642911000}, "page": "218-221", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Breast Milk Jaundice Correlates With High Levels of Epidermal Growth Factor"], "prefix": "10.1038", "volume": "66", "author": [{"given": "Abdullah", "family": "Kumral", "sequence": "first", "affiliation": []}, {"given": "Hasan", "family": "Ozkan", "sequence": "additional", "affiliation": []}, {"given": "Nuray", "family": "Duman", "sequence": "additional", "affiliation": []}, {"given": "Didem Cemile", "family": "Yesilirmak", "sequence": "additional", "affiliation": []}, {"given": "Huray", "family": "Islekel", "sequence": "additional", "affiliation": []}, {"given": "Yilmaz", "family": "Ozalp", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "pr2009191-bib1", "author": "Schneider AP", "volume": "255", "first-page": "3270", "year": "1986", "journal-title": "JAMA", "DOI": "10.1001/jama.1986.03370230076034", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib2", "author": "DeAngelis C", "volume": "79", "first-page": "40", "year": "1980", "journal-title": "Wis Med J"}, {"key": "pr2009191-bib3", "author": "Osborn LM", "volume": "73", "first-page": "520", "year": "1984", "journal-title": "Pediatrics"}, {"key": "pr2009191-bib4", "author": "Saigal S", "volume": "127", "first-page": "985", "year": "1982", "journal-title": "Can Med Assoc J"}, {"key": "pr2009191-bib5", "author": "Maisels MJ", "volume": "78", "first-page": "837", "year": "1986", "journal-title": "Pediatrics"}, {"key": "pr2009191-bib6", "author": "Narayanan I", "volume": "54", "first-page": "257", "year": "1987", "journal-title": "Indian J Pediatr", "DOI": "10.1007/BF02750820", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib7", "author": "Kivlahan C", "volume": "74", "first-page": "364", "year": "1984", "journal-title": "Pediatrics"}, {"key": "pr2009191-bib8", "author": "Stiehm ER", "volume": "109", "first-page": "212", "year": "1965", "journal-title": "Am J Dis Child", "DOI": "10.1001/archpedi.1965.02090020214003", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib9", "author": "Gartner LM", "volume": "68", "first-page": "54", "year": "1966", "journal-title": "J Pediatr", "DOI": "10.1016/S0022-3476(66)80422-5", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib10", "author": "Cole AP", "volume": "47", "first-page": "415", "year": "1972", "journal-title": "Arch Dis Child", "DOI": "10.1136/adc.47.253.415", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib11", "author": "Arthur LJ", "volume": "8", "first-page": "279", "year": "1966", "journal-title": "Dev Med Child Neurol", "DOI": "10.1111/j.1469-8749.1966.tb01748.x", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib12", "unstructured": ""}, {"key": "pr2009191-bib13", "author": "Alonso EM", "volume": "118", "first-page": "425", "year": "1991", "journal-title": "J Pediatr", "DOI": "10.1016/S0022-3476(05)82162-6", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib14", "author": "Arias IM", "volume": "43", "first-page": "2037", "year": "1964", "journal-title": "J Clin Invest", "DOI": "10.1172/JCI105078", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib15", "unstructured": ""}, {"key": "pr2009191-bib16", "author": "Polk DB", "volume": "114", "first-page": "493", "year": "1998", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(98)70532-3", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib17", "author": "Carpenter G", "volume": "80", "first-page": "5627", "year": "1983", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.80.18.5627", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib18", "author": "Todaro GJ", "volume": "77", "first-page": "5258", "year": "1980", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.77.9.5258", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib19", "author": "Rao RK", "volume": "250", "first-page": "G850", "year": "1986", "journal-title": "Am J Physiol"}, {"key": "pr2009191-bib20", "author": "Thompson JF", "volume": "107", "first-page": "1278", "year": "1994", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(94)90528-2", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib21", "author": "Toyoda S", "volume": "886", "first-page": "295", "year": "1986", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/0167-4889(86)90148-5", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib22", "author": "Dvorak B", "volume": "554", "first-page": "407", "year": "2004", "journal-title": "Adv Exp Med Biol", "DOI": "10.1007/978-1-4757-4242-8_52", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib23", "author": "Warner BB", "volume": "150", "first-page": "358", "year": "2007", "journal-title": "J Pediatr", "DOI": "10.1016/j.jpeds.2006.11.059", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib24", "author": "Grimes J", "volume": "199", "first-page": "75", "year": "1992", "journal-title": "Proc Soc Exp Biol Med", "DOI": "10.3181/00379727-199-43332", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib25", "author": "Radfar M", "volume": "59", "first-page": "302", "year": "2005", "journal-title": "Biomed Pharmacother", "DOI": "10.1016/j.biopha.2005.05.003", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib26", "author": "Chang CJ", "volume": "34", "first-page": "394", "year": "2002", "journal-title": "J Pediatr Gastroenterol Nutr", "DOI": "10.1097/00005176-200204000-00015", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib27", "author": "Brown KD", "volume": "139", "first-page": "68", "year": "1983", "journal-title": "Br Vet J", "DOI": "10.1016/S0007-1935(17)30594-8", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib28", "author": "Cera K", "volume": "65", "first-page": "1149", "year": "1987", "journal-title": "J Anim Sci", "DOI": "10.2527/jas1987.6541149x", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib29", "author": "Britton JR", "volume": "30", "first-page": "327", "year": "1989", "journal-title": "Gut", "DOI": "10.1136/gut.30.3.327", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib30", "author": "Berseth CL", "volume": "253", "first-page": "G662", "year": "1987", "journal-title": "Am J Physiol", "DOI": "10.1152/ajpcell.1987.253.5.C662", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib31", "author": "Opleta-Madsen K", "volume": "30", "first-page": "342", "year": "1991", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199110000-00010", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib32", "author": "Thornburg W", "volume": "246", "first-page": "G80", "year": "1984", "journal-title": "Am J Physiol"}, {"key": "pr2009191-bib33", "author": "Kong WY", "volume": "102", "first-page": "661", "year": "1992", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(92)90117-H", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib34", "author": "Herrington MK", "volume": "73", "first-page": "129", "year": "1998", "journal-title": "Biol Neonate", "DOI": "10.1159/000013969", "doi-asserted-by": "crossref"}, {"key": "pr2009191-bib35", "author": "Shinohara H", "volume": "39", "first-page": "281", "year": "1996", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199602000-00016", "doi-asserted-by": "crossref"}], "container-title": ["Pediatric Research"], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T13:33:59Z", "timestamp": 1558445639000}, "score": 59.616524, "issued": {"date-parts": [[2009, 8]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2009, 8]]}, "issue": "2"}, "alternative-id": ["pr2009191"], "URL": "http://dx.doi.org/10.1203/pdr.0b013e3181ac4a30", "relation": {"cites": []}, "ISSN": ["0031-3998", "1530-0447"], "issn-type": [{"value": "0031-3998", "type": "print"}, {"value": "1530-0447", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T03:05:26Z", "timestamp": 1574737526120}, "reference-count": 23, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 11, 1]], "date-time": "2015-11-01T00:00:00Z", "timestamp": 1446336000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2015, 9, 5]], "date-time": "2015-09-05T00:00:00Z", "timestamp": 1441411200000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Nutrition Experimental"], "published-print": {"date-parts": [[2015, 11]]}, "DOI": "10.1016/j.yclnex.2015.08.002", "type": "journal-article", "created": {"date-parts": [[2015, 10, 21]], "date-time": "2015-10-21T19:12:31Z", "timestamp": 1445454751000}, "page": "1-7", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Milk-borne epidermal growth factor modulates bilirubin levels in neonatal rats"], "prefix": "10.1016", "volume": "3", "author": [{"given": "Didem Cemile", "family": "Yesilirmak", "sequence": "first", "affiliation": []}, {"given": "Abdullah", "family": "Kumral", "sequence": "additional", "affiliation": []}, {"given": "Funda", "family": "Tuzun", "sequence": "additional", "affiliation": []}, {"given": "Basak", "family": "Baykara", "sequence": "additional", "affiliation": []}, {"given": "Kazim", "family": "Tugyan", "sequence": "additional", "affiliation": []}, {"given": "Nuray", "family": "Duman", "sequence": "additional", "affiliation": []}, {"given": "Hasan", "family": "\u00d6zkan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Nutrition Experimental"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2352939315000068?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2352939315000068?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 18]], "date-time": "2018-09-18T14:51:12Z", "timestamp": 1537282272000}, "score": 35.890457, "issued": {"date-parts": [[2015, 11]]}, "references-count": 23, "alternative-id": ["S2352939315000068"], "URL": "http://dx.doi.org/10.1016/j.yclnex.2015.08.002", "ISSN": ["2352-9393"], "issn-type": [{"value": "2352-9393", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:32:44Z", "timestamp": 1574515964082}, "reference-count": 23, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Pediatric Gastroenterology and Nutrition"], "published-print": {"date-parts": [[2013, 3]]}, "DOI": "10.1097/mpg.0b013e31827a964b", "type": "journal-article", "created": {"date-parts": [[2012, 11, 17]], "date-time": "2012-11-17T08:16:28Z", "timestamp": 1353140188000}, "page": "328-332", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Breast Milk Jaundice"], "prefix": "10.1097", "volume": "56", "author": [{"given": "Funda", "family": "Tuzun", "sequence": "first", "affiliation": []}, {"given": "Abdullah", "family": "Kumral", "sequence": "additional", "affiliation": []}, {"given": "Nuray", "family": "Duman", "sequence": "additional", "affiliation": []}, {"given": "Hasan", "family": "Ozkan", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Pediatric Gastroenterology and Nutrition"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T06:57:24Z", "timestamp": 1518159444000}, "score": 30.827702, "subtitle": ["Effect of Bacteria Present in Breast Milk and Infant Feces"], "issued": {"date-parts": [[2013, 3]]}, "references-count": 23, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/mpg.0b013e31827a964b", "ISSN": ["0277-2116"], "issn-type": [{"value": "0277-2116", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:06:44Z", "timestamp": 1574287604215}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Res"], "published-print": {"date-parts": [[1992, 4]]}, "DOI": "10.1203/00006450-199204000-00005", "type": "journal-article", "created": {"date-parts": [[2007, 4, 13]], "date-time": "2007-04-13T09:25:11Z", "timestamp": 1176456311000}, "page": "330-334", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Ontogeny of Epidermal Growth Factor, Transforming Growth Factor-\u03b1, Epidermal Growth Factor Receptor, and Thyroid Hormone Receptor RNA Levels in Rat Kidney and Changes in Those Levels Induced by Early Thyroxine Treatment"], "prefix": "10.1038", "volume": "31", "author": [{"given": "Daniel", "family": "North", "sequence": "first", "affiliation": []}, {"given": "Jayaraman", "family": "Lakshmanan", "sequence": "additional", "affiliation": []}, {"given": "Anita", "family": "Reviczky", "sequence": "additional", "affiliation": []}, {"given": "Mathew", "family": "Kaser", "sequence": "additional", "affiliation": []}, {"given": "Delbert A", "family": "Fisher", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Pediatric Research"], "deposited": {"date-parts": [[2012, 1, 25]], "date-time": "2012-01-25T16:08:02Z", "timestamp": 1327507682000}, "score": 29.141315, "issued": {"date-parts": [[1992, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 4]]}, "issue": "4"}, "alternative-id": ["pr199267"], "URL": "http://dx.doi.org/10.1203/00006450-199204000-00005", "ISSN": ["0031-3998", "1530-0447"], "issn-type": [{"value": "0031-3998", "type": "print"}, {"value": "1530-0447", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:09:48Z", "timestamp": 1574287788619}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Res"], "published-print": {"date-parts": [[1984, 11]]}, "DOI": "10.1203/00006450-198411000-00067", "type": "journal-article", "created": {"date-parts": [[2007, 4, 13]], "date-time": "2007-04-13T11:23:13Z", "timestamp": 1176463393000}, "page": "1212-1212", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Nerve growth factor (NGF) and epidermal growth factor (EGF) are present in mouse milk during early lactation"], "prefix": "10.1038", "volume": "18", "author": [{"given": "A", "family": "Grueters", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Lakshmanan", "sequence": "additional", "affiliation": []}, {"given": "D A", "family": "Fisher", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Helge", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Pediatric Research"], "deposited": {"date-parts": [[2012, 1, 25]], "date-time": "2012-01-25T14:55:34Z", "timestamp": 1327503334000}, "score": 28.877886, "issued": {"date-parts": [[1984, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1984, 11]]}, "issue": "11"}, "alternative-id": ["pr19842282"], "URL": "http://dx.doi.org/10.1203/00006450-198411000-00067", "ISSN": ["0031-3998", "1530-0447"], "issn-type": [{"value": "0031-3998", "type": "print"}, {"value": "1530-0447", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T15:39:19Z", "timestamp": 1574437159217}, "publisher-location": "Berlin, Heidelberg", "reference-count": 20, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642836404", "type": "print"}, {"value": "9783642836381", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1989]]}, "DOI": "10.1007/978-3-642-83638-1_9", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 26]], "date-time": "2011-12-26T16:21:05Z", "timestamp": 1324916465000}, "page": "70-77", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Epidermal Growth Factor Receptor in Human Breast Cancer"], "prefix": "10.1007", "author": [{"given": "A. L.", "family": "Harris", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "9_CR1", "doi-asserted-by": "publisher", "first-page": "1328", "DOI": "10.1016/0006-291X(79)91181-1", "volume": "90", "author": "WB Butler", "year": "1979", "unstructured": "Butler WB, Kirkland WL, Jorgensen TL (1979) Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7). Biochem Biophys Res Commun 90: 1328\u20131334", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/0076-6879(85)09079-6", "volume": "109", "author": "G Carpenter", "year": "1985", "unstructured": "Carpenter G (1985) Binding assays for epidermal growth factor. Methods Enzymol 109: 101\u2013110", "journal-title": "Methods Enzymol"}, {"key": "9_CR3", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/S0065-230X(08)60028-7", "volume": "44", "author": "K Dano", "year": "1985", "unstructured": "Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Neilsen LS, Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139\u2013226", "journal-title": "Adv Cancer Res"}, {"key": "9_CR4", "first-page": "1707", "volume": "46", "author": "RB Dickson", "year": "1986", "unstructured": "Dickson RB, Bates SE, McManaway ME, Lippman ME (1986) Characterisation of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 46: 1707\u20131713", "journal-title": "Cancer Res"}, {"key": "9_CR5", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1093/jnci/77.3.621", "volume": "77", "author": "MJ Duffy", "year": "1986", "unstructured": "Duffy MJ, O\u2019Grady P, Simon J, Rose M, Lijnen HR (1986) Tissue type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors. J Natl Cancer lnst 77: 621\u2013623", "journal-title": "J Natl Cancer lnst"}, {"key": "9_CR6", "author": "D Fabbro", "first-page": "23", "year": "1986", "unstructured": "Fabbro D, Wyss R, Borner C, Regazzi R (1986) Epidermal growth factor receptor and calcium/phospholipid-dependent protein kinase activities in human mammary tumour cells. In: Eppenberger U, Fabbro D, Sch\u00e4fer P (eds) Endocrine therapy of breast cancer, Karger, Basel, pp 33\u201344. Contribution to oncology, vol 23", "volume-title": "Endocrine therapy of breast cancer, Karger, Basel, pp 33-44. Contribution to oncology, vol"}, {"key": "9_CR7", "first-page": "3448", "volume": "44", "author": "SL Fitzpatrick", "year": "1984", "unstructured": "Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS (1984) Epidermal growth factor binding by breast tumour biopsies and relationship to estrogen and progestin receptor levels. Cancer Res 44: 3448\u20133453", "journal-title": "Cancer Res"}, {"key": "9_CR8", "doi-asserted-by": "publisher", "first-page": "2276", "DOI": "10.1073/pnas.80.8.2276", "volume": "80", "author": "JL Gross", "year": "1983", "unstructured": "Gross JL, Krupp MN, Rifkin DB, Lane DM (1983) Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells. Proc Natl Acad Sci USA 80: 2276\u20132280", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR9", "doi-asserted-by": "publisher", "first-page": "1702", "DOI": "10.1210/endo-114-5-1702", "volume": "114", "author": "K Huff", "year": "1984", "unstructured": "Huff K, Lippmann ME (1984) Hormonal control of plasminogen activator secretion in ZR-75\u20131 human breast cancer cells in culture. Endocrinol 114: 1702\u20131710", "journal-title": "Endocrinol"}, {"key": "9_CR10", "doi-asserted-by": "publisher", "first-page": "696", "DOI": "10.1038/274696a0", "volume": "274", "author": "LS Lee", "year": "1978", "unstructured": "Lee LS, Weinstein IB (1978) Epidermal growth factor-like phorbol esters induce plasminogen activator in HeLa cells. Nature 274: 696\u2013697", "journal-title": "Nature"}, {"key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1038/bjc.1987.3", "volume": "55", "author": "GK Needham", "year": "1987", "unstructured": "Needham GK, Sherbet GV, Farndon JR, Harris AL (1987) Binding of urokinase to specific receptor sites on human breast cancer membranes. Br J Cancer 55: 13\u201316", "journal-title": "Br J Cancer"}, {"key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1007/BF01806484", "volume": "4", "author": "R Perez", "year": "1984", "unstructured": "Perez R, Pascual M, Macias A, Lage A (1984) Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 4: 189\u2013193", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR13", "first-page": "14324", "volume": "259", "author": "TJ Ryan", "year": "1984", "unstructured": "Ryan TJ, Seeger JI, Kumar SA, Dickerman HW (1984) Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells. J Biol Chem 259: 14324\u201314327", "journal-title": "J Biol Chem"}, {"key": "9_CR14", "doi-asserted-by": "publisher", "first-page": "1225", "DOI": "10.1136/jcp.38.11.1225", "volume": "38", "author": "JRC Sainsbury", "year": "1985", "unstructured": "Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL (1985) Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38: 1225\u20131228", "journal-title": "J Clin Pathol"}, {"key": "9_CR15", "unstructured": "Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL (1985) Epidermal growth factor receptors and oestrogen receptors in human breast cancers. Lancet I: 364\u2013366", "DOI": "10.1016/S0140-6736(85)91385-6", "doi-asserted-by": "crossref"}, {"key": "9_CR16", "unstructured": "Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet I: 1398\u20131402"}, {"key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1016/0277-5379(82)90055-4", "volume": "18", "author": "T Thorsen", "year": "1982", "unstructured": "Thorsen T (1982) Association of plasminogen activator activity and steroid receptors in human breast cancers. Eur J Cancer Clin Oncol 18: 129\u2013132", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "9_CR18", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1159/000132245", "volume": "42", "author": "P Tripputi", "year": "1986", "unstructured": "Tripputi P, Blasi F, Ny T, Emanuel BS, Lefofsky J, Croce CM (1986) Tissue type plasminogen activator gene is on chromosome 8. Cytogenet Cell Genet 42: 24\u201328", "journal-title": "Cytogenet Cell Genet"}, {"key": "9_CR19", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1083/jcb.100.1.86", "volume": "100", "author": "JD Vassalli", "year": "1985", "unstructured": "Vassalli JD, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator urokinase. J Cell Biol 100: 86\u201392", "journal-title": "J Cell Biol"}, {"key": "9_CR20", "unstructured": "Wilson EL, Dutlow C, Dowdle EB (1982) Effect of hormones on the secretion of plasminogen activator by a new line of human breast carcinoma cells, UCT-Br1. In: Growth of Cells in Hormonally Defined Media. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 849\u2013854"}], "container-title": ["Endocrine Therapy and Growth Regulation of Breast Cancer", "Recent Results in Cancer Research"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-83638-1_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T16:00:30Z", "timestamp": 1572883230000}, "score": 27.764965, "issued": {"date-parts": [[1989]]}, "ISBN": ["9783642836404", "9783642836381"], "references-count": 20, "URL": "http://dx.doi.org/10.1007/978-3-642-83638-1_9", "relation": {"cites": []}, "ISSN": ["0080-0015"], "issn-type": [{"value": "0080-0015", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T08:06:32Z", "timestamp": 1575273992436}, "reference-count": 172, "publisher": "Frontiers Media SA", "content-domain": {"domain": ["frontiersin.org"], "crossmark-restriction": true}, "short-container-title": ["Front. Oncol."], "DOI": "10.3389/fonc.2018.00089", "type": "journal-article", "created": {"date-parts": [[2018, 4, 3]], "date-time": "2018-04-03T08:49:23Z", "timestamp": 1522745363000}, "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients"], "prefix": "10.3389", "volume": "8", "author": [{"given": "Alexey A.", "family": "Larionov", "sequence": "first", "affiliation": []}], "member": "1965", "published-online": {"date-parts": [[2018, 4, 3]]}, "reference": [{"key": "B1", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1126/science.3798106", "article-title": "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene", "volume": "235", "author": "Slamon", "year": "1987", "journal-title": "Science"}, {"key": "B2", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1056/NEJM200103153441101", "article-title": "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2", "volume": "344", "author": "Slamon", "year": "2001", "journal-title": "N Engl J Med"}, {"key": "B3", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1186/s13058-015-0648-2", "article-title": "The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer \u2013 a systematic review", "volume": "17", "author": "Mendes", "year": "2015", "journal-title": "Breast Cancer Res"}, {"key": "B4", "doi-asserted-by": "publisher", "first-page": "22", "DOI": "10.4103/0971-5851.203511", "article-title": "Treatment challenges and survival analysis of human epidermal growth factor receptor 2-positive breast cancer in real world", "volume": "38", "author": "Adusumilli", "year": "2017", "journal-title": "Indian J Med Paediatr Oncol"}, {"key": "B5", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1016/j.breast.2016.10.005", "article-title": "Improved survival in metastatic breast cancer 1985\u20132016", "volume": "31", "author": "Sundquist", "year": "2017", "journal-title": "Breast"}, {"key": "B6", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1200/JCO.2008.19.9844", "article-title": "Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review", "volume": "28", "author": "Dawood", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "B7", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1038/nrm1962", "article-title": "EGF-ERBB signalling: towards the systems level", "volume": "7", "author": "Citri", "year": "2006", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "B8", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1016/j.ccr.2014.02.025", "article-title": "ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics", "volume": "25", "author": "Arteaga", "year": "2014", "journal-title": "Cancer Cell"}, {"key": "B9", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.3390/cancers9050052", "article-title": "Epidermal growth factor receptor cell proliferation signaling pathways", "volume": "9", "author": "Wee", "year": "2017", "journal-title": "Cancers (Basel)"}, {"key": "B10", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.1038/nm761", "article-title": "PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest", "volume": "8", "author": "Liang", "year": "2002", "journal-title": "Nat Med"}, {"key": "B11", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.1038/nrd2926", "article-title": "Targeting the phosphoinositide 3-kinase pathway in cancer", "volume": "8", "author": "Liu", "year": "2009", "journal-title": "Nat Rev Drug Discov"}, {"key": "B12", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1016/j.yexcr.2008.10.008", "article-title": "Interaction of antibodies with ErbB receptor extracellular regions", "volume": "315", "author": "Schmitz", "year": "2009", "journal-title": "Exp Cell Res"}, {"key": "B13", "doi-asserted-by": "publisher", "first-page": "244", "DOI": "10.1016/j.breast.2016.10.001", "article-title": "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)", "volume": "31", "author": "Cardoso", "year": "2017", "journal-title": "Breast"}, {"key": "B14", "unstructured": "Breast Cancer Guidelines, Ver. 2.20172017"}, {"key": "B15", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1007/s12094-016-1520-2", "article-title": "Defining the optimal sequence for the systemic treatment of metastatic breast cancer", "volume": "19", "author": "Mestres", "year": "2017", "journal-title": "Clin Transl Oncol"}, {"key": "B16", "first-page": "3384", "article-title": "Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2", "volume": "60", "author": "Klapper", "year": "2000", "journal-title": "Cancer Res"}, {"key": "B17", "first-page": "4744", "article-title": "Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells", "volume": "61", "author": "Molina", "year": "2001", "journal-title": "Cancer Res"}, {"key": "B18", "doi-asserted-by": "publisher", "first-page": "628", "DOI": "10.1093/jnci/djk134", "article-title": "Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer", "volume": "99", "author": "Scaltriti", "year": "2007", "journal-title": "J Natl Cancer Inst"}, {"key": "B19", "first-page": "347", "article-title": "NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer", "volume": "8", "author": "Molina", "year": "2002", "journal-title": "Clin Cancer Res"}, {"key": "B20", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/j.ccr.2004.06.022", "article-title": "PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients", "volume": "6", "author": "Nagata", "year": "2004", "journal-title": "Cancer Cell"}, {"key": "B21", "doi-asserted-by": "publisher", "first-page": "1642", "DOI": "10.1200/JCO.2007.11.6699", "article-title": "Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of cancer and leukemia group B protocol 9840", "volume": "26", "author": "Seidman", "year": "2008", "journal-title": "J Clin Oncol"}, {"key": "B22", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1038/74704", "article-title": "Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets", "volume": "6", "author": "Clynes", "year": "2000", "journal-title": "Nat Med"}, {"key": "B23", "doi-asserted-by": "publisher", "first-page": "1789", "DOI": "10.1200/JCO.2007.14.8957", "article-title": "Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer", "volume": "26", "author": "Musolino", "year": "2008", "journal-title": "J Clin Oncol"}, {"key": "B24", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1016/j.ccr.2010.06.014", "article-title": "The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity", "volume": "18", "author": "Park", "year": "2010", "journal-title": "Cancer Cell"}, {"key": "B25", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1001/jama.2016.18305", "article-title": "Effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with ERBB2 (HER2)-positive metastatic breast cancer: a randomized clinical trial", "volume": "317", "author": "Rugo", "year": "2017", "journal-title": "JAMA"}, {"key": "B26", "doi-asserted-by": "publisher", "first-page": "566", "DOI": "10.1055/s-0035-1546172", "article-title": "Subcutaneous trastuzumab for HER2-positive breast cancer \u2013 evidence and practical experience in 7 German centers", "volume": "75", "author": "Jackisch", "year": "2015", "journal-title": "Geburtshilfe Frauenheilkd"}, {"key": "B27", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1358/dot.2012.48.11.1885879", "article-title": "Pertuzumab for the treatment of patients with previously untreated HER2-positive metastatic breast cancer", "volume": "48", "author": "Smith", "year": "2012", "journal-title": "Drugs Today (Barc)"}, {"key": "B28", "doi-asserted-by": "publisher", "first-page": "2343", "DOI": "10.1158/0008-5472.CAN-03-3856", "article-title": "The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells", "volume": "64", "author": "Nahta", "year": "2004", "journal-title": "Cancer Res"}, {"key": "B29", "doi-asserted-by": "publisher", "first-page": "1138", "DOI": "10.1200/JCO.2009.24.2024", "article-title": "Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy", "volume": "28", "author": "Baselga", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "B30", "doi-asserted-by": "publisher", "first-page": "1134", "DOI": "10.1016/S0140-6736(16)31891-8", "article-title": "Breast cancer", "volume": "389", "author": "Harbeck", "year": "2017", "journal-title": "Lancet"}, {"key": "B31", "doi-asserted-by": "publisher", "first-page": "1594", "DOI": "10.1200/JCO.2011.37.4207", "article-title": "Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer", "volume": "30", "author": "Cortes", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "B32", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1056/NEJMoa1413513", "article-title": "Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer", "volume": "372", "author": "Swain", "year": "2015", "journal-title": "N Engl J Med"}, {"key": "B33", "doi-asserted-by": "publisher", "first-page": "1947", "DOI": "10.1200/JCO.2011.40.5241", "article-title": "Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer", "volume": "31", "author": "Guan", "year": "2013", "journal-title": "J Clin Oncol"}, {"key": "B34", "doi-asserted-by": "publisher", "first-page": "533", "DOI": "10.1007/s10549-007-9885-0", "article-title": "A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses", "volume": "112", "author": "Cameron", "year": "2008", "journal-title": "Breast Cancer Res Treat"}, {"key": "B35", "doi-asserted-by": "publisher", "first-page": "1574", "DOI": "10.1200/JCO.2014.56.9590", "article-title": "Lapatinib or trastuzumab plus taxane therapy for human epidermal growth factor receptor 2-positive advanced breast cancer: final results of NCIC CTG MA.31", "volume": "33", "author": "Gelmon", "year": "2015", "journal-title": "J Clin Oncol"}, {"key": "B36", "doi-asserted-by": "publisher", "first-page": "2585", "DOI": "10.1200/JCO.2011.35.6725", "article-title": "Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study", "volume": "30", "author": "Blackwell", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "B37", "doi-asserted-by": "crossref", "first-page": "abstr1004", "DOI": "10.1200/JCO.2017.35.15_suppl.1004", "article-title": "Phase III study of lapatinib (L) plus trastuzumab (T) and aromatase inhibitor (AI) vs T+AI vs L+AI in postmenopausal women (PMW) with HER2+, HR+ metastatic breast cancer (MBC): ALTERNATIVE", "volume": "35", "author": "Gradishar", "year": "2017", "journal-title": "J Clin Oncol"}, {"key": "B38", "doi-asserted-by": "publisher", "first-page": "1564", "DOI": "10.1200/JCO.2014.57.1794", "article-title": "CEREBEL (EGF111438): a phase III, randomized, open-label study of lapatinib Plus capecitabine versus trastuzumab plus capecitabine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer", "volume": "33", "author": "Pivot", "year": "2015", "journal-title": "J Clin Oncol"}, {"key": "B39", "doi-asserted-by": "publisher", "first-page": "1015", "DOI": "10.1007/s12325-017-0519-6", "article-title": "Antibody-drug conjugates (ADCs) for personalized treatment of solid tumors: a review", "volume": "34", "author": "Lambert", "year": "2017", "journal-title": "Adv Ther"}, {"key": "B40", "doi-asserted-by": "publisher", "first-page": "6949", "DOI": "10.1021/jm500766w", "article-title": "Ado-trastuzumab emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer", "volume": "57", "author": "Lambert", "year": "2014", "journal-title": "J Med Chem"}, {"key": "B41", "first-page": "113", "article-title": "A therapeutic trial of maytansine", "volume": "1", "author": "Blum", "year": "1978", "journal-title": "Cancer Clin Trials"}, {"key": "B42", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1200/JCO.2016.67.4887", "article-title": "Trastuzumab emtansine with or without pertuzumab versus trastuzumab plus taxane for human epidermal growth factor receptor 2-positive, advanced breast cancer: primary results from the phase III MARIANNE study", "volume": "35", "author": "Perez", "year": "2017", "journal-title": "J Clin Oncol"}, {"key": "B43", "doi-asserted-by": "publisher", "first-page": "1783", "DOI": "10.1056/NEJMoa1209124", "article-title": "Trastuzumab emtansine for HER2-positive advanced breast cancer", "volume": "367", "author": "Verma", "year": "2012", "journal-title": "N Engl J Med"}, {"key": "B44", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1016/S1470-2045(14)70178-0", "article-title": "Trastuzumab emtansine versus treatment of physician\u2019s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial", "volume": "15", "author": "Krop", "year": "2014", "journal-title": "Lancet Oncol"}, {"key": "B45", "doi-asserted-by": "publisher", "first-page": "743", "DOI": "10.1016/S1470-2045(17)30313-3", "article-title": "Trastuzumab emtansine versus treatment of physician\u2019s choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial", "volume": "18", "author": "Krop", "year": "2017", "journal-title": "Lancet Oncol"}, {"key": "B46", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1016/S1470-2045(17)30312-1", "article-title": "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial", "volume": "18", "author": "Dieras", "year": "2017", "journal-title": "Lancet Oncol"}, {"key": "B47", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1186/s13058-016-0691-7", "article-title": "Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer", "volume": "18", "author": "Krop", "year": "2016", "journal-title": "Breast Cancer Res"}, {"key": "B48", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1200/JCO.2002.20.3.719", "article-title": "Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer", "volume": "20", "author": "Vogel", "year": "2002", "journal-title": "J Clin Oncol"}, {"key": "B49", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/j.clbc.2011.03.003", "article-title": "Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial", "volume": "11", "author": "Hamberg", "year": "2011", "journal-title": "Clin Breast Cancer"}, {"key": "B50", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1007/s10549-009-0498-7", "article-title": "Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 trial group", "volume": "119", "author": "Inoue", "year": "2010", "journal-title": "Breast Cancer Res Treat"}, {"key": "B51", "doi-asserted-by": "publisher", "first-page": "2241", "DOI": "10.1038/sj.onc.1202526", "article-title": "Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers", "volume": "18", "author": "Pegram", "year": "1999", "journal-title": "Oncogene"}, {"key": "B52", "doi-asserted-by": "publisher", "first-page": "3015", "DOI": "10.1158/1535-7163.MCT-09-0219", "article-title": "Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents", "volume": "8", "author": "Boone", "year": "2009", "journal-title": "Mol Cancer Ther"}, {"key": "B53", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.4103/1477-3163.90442", "article-title": "Mechanisms of trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance", "volume": "10", "author": "Bailey", "year": "2011", "journal-title": "J Carcinog"}, {"key": "B54", "doi-asserted-by": "publisher", "first-page": "1640", "DOI": "10.1158/0008-5472.CAN-05-2000", "article-title": "Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers", "volume": "66", "author": "Xia", "year": "2006", "journal-title": "Cancer Res"}, {"key": "B55", "doi-asserted-by": "publisher", "first-page": "1326", "DOI": "10.1158/1078-0432.CCR-08-0954", "article-title": "Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance", "volume": "15", "author": "Lu", "year": "2009", "journal-title": "Clin Cancer Res"}, {"key": "B56", "first-page": "2462", "article-title": "Regulation of microtubule stability and mitotic progression by survivin", "volume": "62", "author": "Giodini", "year": "2002", "journal-title": "Cancer Res"}, {"key": "B57", "doi-asserted-by": "publisher", "first-page": "1215", "DOI": "10.1200/JCO.2002.20.5.1215", "article-title": "Cardiac dysfunction in the trastuzumab clinical trials experience", "volume": "20", "author": "Seidman", "year": "2002", "journal-title": "J Clin Oncol"}, {"key": "B58", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1634/theoncologist.2007-0204", "article-title": "Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer", "volume": "13", "author": "Bullock", "year": "2008", "journal-title": "Oncologist"}, {"key": "B59", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1200/JCO.2010.30.8213", "article-title": "Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study", "volume": "29", "author": "Andersson", "year": "2011", "journal-title": "J Clin Oncol"}, {"key": "B60", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1186/s13058-016-0773-6", "article-title": "Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results", "volume": "18", "author": "Perez", "year": "2016", "journal-title": "Breast Cancer Res"}, {"key": "B61", "doi-asserted-by": "publisher", "first-page": "976", "DOI": "10.1200/JCO.2008.21.6531", "article-title": "Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer", "volume": "28", "author": "Wardley", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "B62", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1200/JCO.2010.28.6450", "article-title": "Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens", "volume": "29", "author": "Valero", "year": "2011", "journal-title": "J Clin Oncol"}, {"key": "B63", "doi-asserted-by": "publisher", "first-page": "1999", "DOI": "10.1200/JCO.2008.19.6618", "article-title": "Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a German breast group 26/breast international group 03-05 study", "volume": "27", "author": "von Minckwitz", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "B64", "doi-asserted-by": "publisher", "first-page": "2733", "DOI": "10.1056/NEJMoa064320", "article-title": "Lapatinib plus capecitabine for HER2-positive advanced breast cancer", "volume": "355", "author": "Geyer", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "B65", "doi-asserted-by": "publisher", "first-page": "3853", "DOI": "10.1200/JCO.2007.11.9776", "article-title": "Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer", "volume": "25", "author": "Bartsch", "year": "2007", "journal-title": "J Clin Oncol"}, {"key": "B66", "doi-asserted-by": "publisher", "first-page": "dju055", "DOI": "10.1093/jnci/dju055", "article-title": "US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status", "volume": "106", "author": "Howlader", "year": "2014", "journal-title": "J Natl Cancer Inst"}, {"key": "B67", "doi-asserted-by": "publisher", "first-page": "17932", "DOI": "10.18632/oncotarget.7480", "article-title": "\u201cTriple positive\u201d early breast cancer: an observational multicenter retrospective analysis of outcome", "volume": "7", "author": "Vici", "year": "2016", "journal-title": "Oncotarget"}, {"key": "B68", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/j.jsbmb.2015.05.005", "article-title": "From bench to bedside: what do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?", "volume": "153", "author": "Wu", "year": "2015", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "B69", "doi-asserted-by": "publisher", "first-page": "2078", "DOI": "10.1200/JCO.2013.54.0948", "article-title": "Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American society of clinical oncology clinical practice guideline", "volume": "32", "author": "Giordano", "year": "2014", "journal-title": "J Clin Oncol"}, {"key": "B70", "doi-asserted-by": "publisher", "first-page": "5529", "DOI": "10.1200/JCO.2008.20.6847", "article-title": "Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study", "volume": "27", "author": "Kaufman", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "B71", "doi-asserted-by": "publisher", "first-page": "5538", "DOI": "10.1200/JCO.2009.23.3734", "article-title": "Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer", "volume": "27", "author": "Johnston", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "B72", "doi-asserted-by": "publisher", "first-page": "523", "DOI": "10.1007/s10549-012-2336-6", "article-title": "Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer", "volume": "137", "author": "Hayashi", "year": "2013", "journal-title": "Breast Cancer Res Treat"}, {"key": "B73", "doi-asserted-by": "publisher", "first-page": "2997", "DOI": "10.1016/S0140-6736(16)32389-3", "article-title": "Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial", "volume": "388", "author": "Robertson", "year": "2016", "journal-title": "Lancet"}, {"key": "B74", "doi-asserted-by": "publisher", "first-page": "R77", "DOI": "10.1186/bcr2419", "article-title": "PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro", "volume": "11", "author": "Finn", "year": "2009", "journal-title": "Breast Cancer Res"}, {"key": "B75", "doi-asserted-by": "publisher", "first-page": "1738", "DOI": "10.1056/NEJMoa1609709", "article-title": "Ribociclib as first-line therapy for HR-positive, advanced breast cancer", "volume": "375", "author": "Hortobagyi", "year": "2016", "journal-title": "N Engl J Med"}, {"key": "B76", "doi-asserted-by": "publisher", "first-page": "1028", "DOI": "10.1634/theoncologist.2017-0072", "article-title": "Palbociclib combined with fulvestrant in premenopausal women with advanced breast cancer and prior progression on endocrine therapy: PALOMA-3 results", "volume": "22", "author": "Loibl", "year": "2017", "journal-title": "Oncologist"}, {"key": "B77", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1093/annonc/mdw544", "article-title": "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)", "volume": "28", "author": "Cardoso", "year": "2017", "journal-title": "Ann Oncol"}, {"key": "B78", "doi-asserted-by": "publisher", "first-page": "3030", "DOI": "10.1200/JCO.2016.70.6267", "article-title": "Randomized phase III trial of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who experienced disease progression during or after trastuzumab-based therapy", "volume": "35", "author": "Urruticoechea", "year": "2017", "journal-title": "J Clin Oncol"}, {"key": "B79", "doi-asserted-by": "publisher", "first-page": "924", "DOI": "10.1634/theoncologist.2009-0181", "article-title": "Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial", "volume": "15", "author": "Cameron", "year": "2010", "journal-title": "Oncologist"}, {"key": "B80", "doi-asserted-by": "publisher", "first-page": "1124", "DOI": "10.1200/JCO.2008.21.4437", "article-title": "Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer", "volume": "28", "author": "Blackwell", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "B81", "doi-asserted-by": "publisher", "first-page": "2273", "DOI": "10.1016/j.ejca.2011.06.021", "article-title": "Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer", "volume": "47", "author": "von Minckwitz", "year": "2011", "journal-title": "Eur J Cancer"}, {"key": "B82", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1634/theoncologist.2011-0187", "article-title": "Advances in first-line treatment for patients with HER-2+ metastatic breast cancer", "volume": "17", "author": "De Mattos-Arruda", "year": "2012", "journal-title": "Oncologist"}, {"key": "B83", "doi-asserted-by": "publisher", "first-page": "946", "DOI": "10.1007/s12094-015-1476-7", "article-title": "SEOM clinical guidelines in metastatic breast cancer 2015", "volume": "17", "author": "Gavila", "year": "2015", "journal-title": "Clin Transl Oncol"}, {"key": "B84", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1159/000443601", "article-title": "Anti-HER2 therapy beyond second-line for HER2-positive metastatic breast cancer: a short review and recommendations for several clinical scenarios from a Spanish expert panel", "volume": "11", "author": "Martinez-Janez", "year": "2016", "journal-title": "Breast Care (Basel)"}, {"key": "B85", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1159/000431248", "article-title": "AGO recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer: update 2015", "volume": "10", "author": "Liedtke", "year": "2015", "journal-title": "Breast Care (Basel)"}, {"key": "B86", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1038/ncponc1179", "article-title": "The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2", "volume": "5", "author": "Prat", "year": "2008", "journal-title": "Nat Clin Pract Oncol"}, {"key": "B87", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1177/1758834016665077", "article-title": "Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies", "volume": "8", "author": "Lousberg", "year": "2016", "journal-title": "Ther Adv Med Oncol"}, {"key": "B88", "doi-asserted-by": "publisher", "first-page": "e0177331", "DOI": "10.1371/journal.pone.0177331", "article-title": "Direct estrogen receptor (ER)/HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer", "volume": "12", "author": "Collins", "year": "2017", "journal-title": "PLoS One"}, {"key": "B89", "doi-asserted-by": "publisher", "first-page": "R121", "DOI": "10.1186/bcr3067", "article-title": "Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers \u2013 role of estrogen receptor and HER2 reactivation", "volume": "13", "author": "Wang", "year": "2011", "journal-title": "Breast Cancer Res"}, {"key": "B90", "doi-asserted-by": "publisher", "first-page": "3995", "DOI": "10.1158/1078-0432.CCR-14-2728", "article-title": "Upregulation of ER signaling as an adaptive mechanism of cell survival in HER2-positive breast tumors treated with anti-HER2 therapy", "volume": "21", "author": "Giuliano", "year": "2015", "journal-title": "Clin Cancer Res"}, {"key": "B91", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1159/000354253", "article-title": "Bidirectional crosstalk between the estrogen receptor and human epidermal growth factor receptor 2 signaling pathways in breast cancer: molecular basis and clinical implications", "volume": "8", "author": "Giuliano", "year": "2013", "journal-title": "Breast Care (Basel)"}, {"key": "B92", "doi-asserted-by": "publisher", "first-page": "122", "DOI": "10.1634/theoncologist.2009-0240", "article-title": "Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer", "volume": "15", "author": "Schwartzberg", "year": "2010", "journal-title": "Oncologist"}, {"key": "B93", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/j.breast.2011.07.006", "article-title": "Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer \u2013 results of the eLEcTRA trial", "volume": "21", "author": "Huober", "year": "2012", "journal-title": "Breast"}, {"key": "B94", "volume": "365", "first-page": "1687", "year": "2005", "article-title": "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(05)66544-0", "doi-asserted-by": "publisher"}, {"key": "B95", "doi-asserted-by": "publisher", "first-page": "1658", "DOI": "10.1001/jama.295.14.1658", "article-title": "Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer", "volume": "295", "author": "Berry", "year": "2006", "journal-title": "JAMA"}, {"key": "B96", "author": "Arpino", "volume": "77", "year": "2017", "article-title": "Primary analysis of PERTAIN: a randomized, two-arm, open-label, multicenter phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab plus an aromatase inhibitor in first-line patients with HER2-positive and hormone receptor-positive metastatic or locally advanced breast cancer", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.SABCS16-S3-04", "doi-asserted-by": "publisher"}, {"key": "B97", "doi-asserted-by": "publisher", "first-page": "1925", "DOI": "10.1056/NEJMoa1607303", "article-title": "Palbociclib and letrozole in advanced breast cancer", "volume": "375", "author": "Finn", "year": "2016", "journal-title": "N Engl J Med"}, {"key": "B98", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1007/s11912-017-0591-8", "article-title": "The evolving role of the estrogen receptor mutations in endocrine therapy-resistant breast cancer", "volume": "19", "author": "Jeselsohn", "year": "2017", "journal-title": "Curr Oncol Rep"}, {"key": "B99", "doi-asserted-by": "publisher", "first-page": "45411", "DOI": "10.1038/srep45411", "article-title": "Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study", "volume": "7", "author": "Gong", "year": "2017", "journal-title": "Sci Rep"}, {"key": "B100", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1186/s40164-015-0028-8", "article-title": "Breast cancer brain metastases: the last frontier", "volume": "4", "author": "Leone", "year": "2015", "journal-title": "Exp Hematol Oncol"}, {"key": "B101", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1007/s00404-016-4225-4", "article-title": "Pattern of metastatic spread and subcategories of breast cancer", "volume": "295", "author": "Bartmann", "year": "2017", "journal-title": "Arch Gynecol Obstet"}, {"key": "B102", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1016/j.breast.2014.06.009", "article-title": "Metastatic breast cancer subtypes and central nervous system metastases", "volume": "23", "author": "Aversa", "year": "2014", "journal-title": "Breast"}, {"key": "B103", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1016/j.cdtm.2017.01.004", "article-title": "Management of breast cancer brain metastases: focus on human epidermal growth factor receptor 2-positive breast cancer", "volume": "3", "author": "Yuan", "year": "2017", "journal-title": "Chronic Dis Transl Med"}, {"key": "B104", "doi-asserted-by": "publisher", "first-page": "2100", "DOI": "10.1200/JCO.2013.54.0955", "article-title": "Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American society of clinical oncology clinical practice guideline", "volume": "32", "author": "Ramakrishna", "year": "2014", "journal-title": "J Clin Oncol"}, {"key": "B105", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1093/neuonc/now241", "article-title": "Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)", "volume": "19", "author": "Soffietti", "year": "2017", "journal-title": "Neuro Oncol"}, {"key": "B106", "doi-asserted-by": "publisher", "first-page": "1089", "DOI": "10.1517/14656561003702412", "article-title": "Systemic treatment in breast-cancer patients with brain metastasis", "volume": "11", "author": "Arslan", "year": "2010", "journal-title": "Expert Opin Pharmacother"}, {"key": "B107", "doi-asserted-by": "publisher", "first-page": "2972", "DOI": "10.1002/cncr.11436", "article-title": "Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma", "volume": "97", "author": "Bendell", "year": "2003", "journal-title": "Cancer"}, {"key": "B108", "doi-asserted-by": "publisher", "first-page": "766", "DOI": "10.1634/theoncologist.12-7-766", "article-title": "Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors", "volume": "12", "author": "Gori", "year": "2007", "journal-title": "Oncologist"}, {"key": "B109", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.1038/sj.bjc.6601970", "article-title": "Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer", "volume": "91", "author": "Clayton", "year": "2004", "journal-title": "Br J Cancer"}, {"key": "B110", "doi-asserted-by": "publisher", "first-page": "894", "DOI": "10.1038/sj.bjc.6604941", "article-title": "Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients", "volume": "100", "author": "Park", "year": "2009", "journal-title": "Br J Cancer"}, {"key": "B111", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1007/s11060-016-2075-3", "article-title": "Brain metastasis in breast cancer: a comprehensive literature review", "volume": "127", "author": "Rostami", "year": "2016", "journal-title": "J Neurooncol"}, {"key": "B112", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1097/01.cad.0000236313.50833.ee", "article-title": "Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier", "volume": "18", "author": "Stemmler", "year": "2007", "journal-title": "Anticancer Drugs"}, {"key": "B113", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1093/neuonc/nou141", "article-title": "Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study", "volume": "17", "author": "Morikawa", "year": "2015", "journal-title": "Neuro Oncol"}, {"key": "B114", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.3332/ecancer.2013.307", "article-title": "Breast cancer brain metastases: new directions in systemic therapy", "volume": "7", "author": "Lin", "year": "2013", "journal-title": "Ecancermedicalscience"}, {"key": "B115", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1016/S1470-2045(12)70432-1", "article-title": "Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study", "volume": "14", "author": "Bachelot", "year": "2013", "journal-title": "Lancet Oncol"}, {"key": "B116", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1093/annonc/mdu486", "article-title": "Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA", "volume": "26", "author": "Krop", "year": "2015", "journal-title": "Ann Oncol"}, {"key": "B117", "doi-asserted-by": "publisher", "first-page": "1116", "DOI": "10.1093/annonc/mdu133", "article-title": "Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA", "volume": "25", "author": "Swain", "year": "2014", "journal-title": "Ann Oncol"}, {"key": "B118", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1177/1758834016656494", "article-title": "Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness", "volume": "8", "author": "Chan", "year": "2016", "journal-title": "Ther Adv Med Oncol"}, {"key": "B119", "doi-asserted-by": "publisher", "first-page": "989", "DOI": "10.4155/tde.15.48", "article-title": "Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer", "volume": "6", "author": "Papademetriou", "year": "2015", "journal-title": "Ther Deliv"}, {"key": "B120", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/j.canlet.2004.11.015", "article-title": "Antitumor activity of HER-2 inhibitors", "volume": "227", "author": "Rabindran", "year": "2005", "journal-title": "Cancer Lett"}, {"key": "B121", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1016/S1470-2045(15)00551-3", "article-title": "Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial", "volume": "17", "author": "Chan", "year": "2016", "journal-title": "Lancet Oncol"}, {"key": "B122", "doi-asserted-by": "publisher", "first-page": "1557", "DOI": "10.1001/jamaoncol.2016.0237", "article-title": "Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: the NEfERT-T randomized clinical trial", "volume": "2", "author": "Awada", "year": "2016", "journal-title": "JAMA Oncol"}, {"key": "B123", "doi-asserted-by": "publisher", "first-page": "3763", "DOI": "10.1016/j.ejca.2013.07.142", "article-title": "A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer", "volume": "49", "author": "Martin", "year": "2013", "journal-title": "Eur J Cancer"}, {"key": "B124", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1016/S1470-2045(15)00540-9", "article-title": "Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial", "volume": "17", "author": "Harbeck", "year": "2016", "journal-title": "Lancet Oncol"}, {"key": "B125", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1016/S1470-2045(16)00004-8", "article-title": "Lessons from breast cancer trials of HER2-kinase inhibitors", "volume": "17", "author": "Krop", "year": "2016", "journal-title": "Lancet Oncol"}, {"key": "B126", "doi-asserted-by": "publisher", "first-page": "3529", "DOI": "10.1158/1078-0432.CCR-16-1496", "article-title": "Phase I study of ONT-380, a HER2 inhibitor, in patients with HER2+-advanced solid tumors, with an expansion cohort in HER2+ metastatic breast cancer (MBC)", "volume": "23", "author": "Moulder", "year": "2017", "journal-title": "Clin Cancer Res"}, {"key": "B127", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1200/JCO.2016.34.15_suppl.513", "article-title": "Efficacy results of a phase 1b study of ONT-380, a CNS-penetrant TKI, in combination with T-DM1 in HER2+ metastatic breast cancer (MBC), including patients (pts) with brain metastases", "volume": "34", "author": "Borges", "year": "2016", "journal-title": "J Clin Oncol"}, {"key": "B128", "doi-asserted-by": "publisher", "first-page": "520", "DOI": "10.1056/NEJMoa1109653", "article-title": "Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer", "volume": "366", "author": "Baselga", "year": "2012", "journal-title": "N Engl J Med"}, {"key": "B129", "doi-asserted-by": "publisher", "first-page": "816", "DOI": "10.1016/S1470-2045(15)00051-0", "article-title": "Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial", "volume": "16", "author": "Hurvitz", "year": "2015", "journal-title": "Lancet Oncol"}, {"key": "B130", "author": "Yardley", "volume": "77", "year": "2017", "article-title": "Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: overall survival results from BOLERO-1", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.SABCS16-P4-22-13", "doi-asserted-by": "publisher"}, {"key": "B131", "doi-asserted-by": "publisher", "first-page": "580", "DOI": "10.1016/S1470-2045(14)70138-X", "article-title": "Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial", "volume": "15", "author": "Andre", "year": "2014", "journal-title": "Lancet Oncol"}, {"key": "B132", "author": "Isaacs", "volume": "76", "year": "2016", "article-title": "Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: overall survival results from BOLERO-3", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.SABCS15-P4-13-12", "doi-asserted-by": "publisher"}, {"key": "B133", "doi-asserted-by": "publisher", "first-page": "2115", "DOI": "10.1200/JCO.2015.63.9161", "article-title": "Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2-overexpressing metastatic breast cancers: combined exploratory biomarker analysis from BOLERO-1 and BOLERO-3", "volume": "34", "author": "Andre", "year": "2016", "journal-title": "J Clin Oncol"}, {"key": "B134", "doi-asserted-by": "publisher", "first-page": "1463", "DOI": "10.2217/fon.15.56", "article-title": "Buparlisib in breast cancer", "volume": "11", "author": "Sirohi", "year": "2015", "journal-title": "Future Oncol"}, {"key": "B135", "author": "Jain", "volume": "76", "year": "2015", "article-title": "Phase I study of alpelisib and T-DM1 in trastuzumab-refractory HER2-positive metastatic breast cancer", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.SABCS15-P6-13-11", "doi-asserted-by": "publisher"}, {"key": "B136", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1038/nrm3629", "article-title": "Control of cell cycle transcription during G1 and S phases", "volume": "14", "author": "Bertoli", "year": "2013", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "B137", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1023/A:1023033708204", "article-title": "Cyclin D1, EMS1 and 11q13 amplification in breast cancer", "volume": "78", "author": "Ormandy", "year": "2003", "journal-title": "Breast Cancer Res Treat"}, {"key": "B138", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1038/35082500", "article-title": "Specific protection against breast cancers by cyclin D1 ablation", "volume": "411", "author": "Yu", "year": "2001", "journal-title": "Nature"}, {"key": "B139", "doi-asserted-by": "publisher", "first-page": "1415", "DOI": "10.1210/me.2013-1065", "article-title": "Cyclin D1 determines estrogen signaling in the mammary gland in vivo", "volume": "27", "author": "Casimiro", "year": "2013", "journal-title": "Mol Endocrinol"}, {"key": "B140", "doi-asserted-by": "publisher", "first-page": "2875", "DOI": "10.1200/JCO.2017.73.7585", "article-title": "MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2- advanced breast cancer who had progressed while receiving endocrine therapy", "volume": "35", "author": "Sledge", "year": "2017", "journal-title": "J Clin Oncol"}, {"key": "B141", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1056/NEJMoa1505270", "article-title": "Palbociclib in hormone-receptor-positive advanced breast cancer", "volume": "373", "author": "Turner", "year": "2015", "journal-title": "N Engl J Med"}, {"key": "B142", "doi-asserted-by": "publisher", "first-page": "1543", "DOI": "10.3390/ijms17091543", "article-title": "Targeted therapies for brain metastases from breast cancer", "volume": "17", "author": "Venur", "year": "2016", "journal-title": "Int J Mol Sci"}, {"key": "B143", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.18632/genesandcancer.24", "article-title": "CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models", "volume": "5", "author": "Witkiewicz", "year": "2014", "journal-title": "Genes Cancer"}, {"key": "B144", "doi-asserted-by": "publisher", "first-page": "208", "DOI": "10.1016/j.critrevonc.2017.02.022", "article-title": "CDK4/6 inhibitors in HER2-positive breast cancer", "volume": "112", "author": "Corona", "year": "2017", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "B145", "doi-asserted-by": "publisher", "first-page": "20521", "DOI": "10.18632/oncotarget.16266", "article-title": "HSP90 proteins in the scenario of tumor complexity", "volume": "8", "author": "Rasola", "year": "2017", "journal-title": "Oncotarget"}, {"key": "B146", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1038/onc.2009.337", "article-title": "Inhibitors of HSP90 block p95-HER2 signaling in trastuzumab-resistant tumors and suppress their growth", "volume": "29", "author": "Chandarlapaty", "year": "2010", "journal-title": "Oncogene"}, {"key": "B147", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1007/s10637-013-9971-6", "article-title": "Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes", "volume": "32", "author": "Friedland", "year": "2014", "journal-title": "Invest New Drugs"}, {"key": "B148", "doi-asserted-by": "publisher", "first-page": "5132", "DOI": "10.1158/1078-0432.CCR-11-0072", "article-title": "HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab", "volume": "17", "author": "Modi", "year": "2011", "journal-title": "Clin Cancer Res"}, {"key": "B149", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1007/s10549-013-2510-5", "article-title": "A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer", "volume": "139", "author": "Modi", "year": "2013", "journal-title": "Breast Cancer Res Treat"}, {"key": "B150", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1016/B978-0-12-407697-6.00005-2", "article-title": "Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally", "volume": "303", "author": "Li", "year": "2013", "journal-title": "Int Rev Cell Mol Biol"}, {"key": "B151", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.1517/13543784.2014.902442", "article-title": "Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions", "volume": "23", "author": "Jhaveri", "year": "2014", "journal-title": "Expert Opin Investig Drugs"}, {"key": "B152", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1038/35025220", "article-title": "Angiogenesis in cancer and other diseases", "volume": "407", "author": "Carmeliet", "year": "2000", "journal-title": "Nature"}, {"key": "B153", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1016/j.bbrc.2004.11.053", "article-title": "ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter", "volume": "326", "author": "Loureiro", "year": "2005", "journal-title": "Biochem Biophys Res Commun"}, {"key": "B154", "doi-asserted-by": "publisher", "first-page": "1706", "DOI": "10.1158/1078-0432.CCR-0951-3", "article-title": "Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients", "volume": "10", "author": "Konecny", "year": "2004", "journal-title": "Clin Cancer Res"}, {"key": "B155", "doi-asserted-by": "publisher", "first-page": "1285", "DOI": "10.1007/s10637-014-0122-5", "article-title": "A phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer", "volume": "32", "author": "Zhao", "year": "2014", "journal-title": "Invest New Drugs"}, {"key": "B156", "doi-asserted-by": "publisher", "first-page": "1719", "DOI": "10.1200/JCO.2012.44.7912", "article-title": "AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer", "volume": "31", "author": "Gianni", "year": "2013", "journal-title": "J Clin Oncol"}, {"key": "B157", "author": "Slamon", "volume": "73", "year": "2013", "article-title": "Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab \u00b1 bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer", "journal-title": "Cancer Res", "DOI": "10.1158/0008-5472.SABCS13-S1-03", "doi-asserted-by": "publisher"}, {"key": "B158", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1093/jjco/hyt201", "article-title": "Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trials", "volume": "44", "author": "Fakhrejahani", "year": "2014", "journal-title": "Jpn J Clin Oncol"}, {"key": "B159", "doi-asserted-by": "publisher", "first-page": "e51", "DOI": "10.3747/co.22.2210", "article-title": "Use of bevacizumab as a first-line treatment for metastatic breast cancer", "volume": "22", "author": "Manso", "year": "2015", "journal-title": "Curr Oncol"}, {"key": "B160", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1248/yakushi.16-00255-4", "article-title": "Development of new ADC technology with topoisomerase I inhibitor", "volume": "137", "author": "Agatsuma", "year": "2017", "journal-title": "Yakugaku Zasshi"}, {"key": "B161", "doi-asserted-by": "publisher", "first-page": "LBA17", "DOI": "10.1093/annonc/mdw435.07", "article-title": "Single agent activity of DS-8201a, a HER2-targeting antibody-drug conjugate, in breast cancer patients previously treated with T-DM1: phase 1 dose escalation", "volume": "27", "author": "Tamura", "year": "2016", "journal-title": "Ann Oncol"}, {"key": "B162", "author": "Bergstrom", "volume": "75", "year": "2015", "article-title": "A novel, highly potent HER2-targeted antibody-drug conjugate (ADC) for the treatment of low HER2-expressing tumors and combination with trastuzumab based regimens in HER2-driven tumors", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.AM2015-LB-231", "doi-asserted-by": "publisher"}, {"key": "B163", "doi-asserted-by": "publisher", "first-page": "352", "DOI": "10.1186/s12885-016-2385-z", "article-title": "HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician\u2019s choice plus trastuzumab in patients with previously treated, anthracycline-naive, HER2-positive, locally advanced/metastatic breast cancer", "volume": "16", "author": "Miller", "year": "2016", "journal-title": "BMC Cancer"}, {"key": "B164", "doi-asserted-by": "publisher", "first-page": "914", "DOI": "10.1016/j.ejmech.2016.10.015", "article-title": "Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells", "volume": "125", "author": "Pallerla", "year": "2017", "journal-title": "Eur J Med Chem"}, {"key": "B165", "doi-asserted-by": "publisher", "first-page": "42069", "DOI": "10.1038/srep42069", "article-title": "Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer", "volume": "7", "author": "Kang", "year": "2017", "journal-title": "Sci Rep"}, {"key": "B166", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1093/annonc/mdx002", "article-title": "First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors", "volume": "28", "author": "Bang", "year": "2017", "journal-title": "Ann Oncol"}, {"key": "B167", "author": "Rugo", "volume": "77", "year": "2017", "article-title": "SOPHIA: a phase 3, randomized study of margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in the treatment of patients with HER2+ metastatic breast cancer", "journal-title": "Cancer Res", "DOI": "10.1158/1538-7445.SABCS16-OT1-02-07", "doi-asserted-by": "publisher"}, {"key": "B168", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1186/s12885-016-2449-0", "article-title": "A phase I trial of the trifunctional anti Her2 x anti CD3 antibody ertumaxomab in patients with advanced solid tumors", "volume": "16", "author": "Haense", "year": "2016", "journal-title": "BMC Cancer"}, {"key": "B169", "doi-asserted-by": "publisher", "first-page": "3085", "DOI": "10.1158/1078-0432.CCR-05-2436", "article-title": "Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer", "volume": "12", "author": "Kiewe", "year": "2006", "journal-title": "Clin Cancer Res"}, {"key": "B170", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1007/s00262-013-1489-4", "article-title": "HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers", "volume": "63", "author": "Disis", "year": "2014", "journal-title": "Cancer Immunol Immunother"}, {"key": "B171", "doi-asserted-by": "publisher", "first-page": "4685", "DOI": "10.1200/JCO.2008.20.6789", "article-title": "Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer", "volume": "27", "author": "Disis", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "B172", "doi-asserted-by": "publisher", "first-page": "1195", "DOI": "10.1016/S0140-6736(16)32616-2", "article-title": "11 years\u2019 follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin adjuvant (HERA) trial", "volume": "389", "author": "Cameron", "year": "2017", "journal-title": "Lancet"}], "container-title": ["Frontiers in Oncology"], "link": [{"URL": "http://journal.frontiersin.org/article/10.3389/fonc.2018.00089/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T23:13:02Z", "timestamp": 1571008382000}, "score": 27.394463, "issued": {"date-parts": [[2018, 4, 3]]}, "references-count": 172, "alternative-id": ["10.3389/fonc.2018.00089"], "URL": "http://dx.doi.org/10.3389/fonc.2018.00089", "relation": {"cites": []}, "ISSN": ["2234-943X"], "issn-type": [{"value": "2234-943X", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:46:16Z", "timestamp": 1574124376465}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1984, 1, 1]], "date-time": "1984-01-01T00:00:00Z", "timestamp": 441763200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cell"], "published-print": {"date-parts": [[1984, 1]]}, "DOI": "10.1016/0092-8674(84)90071-0", "type": "journal-article", "created": {"date-parts": [[2004, 4, 30]], "date-time": "2004-04-30T10:02:47Z", "timestamp": 1083319367000}, "page": "35-41", "source": "Crossref", "is-referenced-by-count": 132, "title": ["Transforming growth factor-\u03b2 controls receptor levels for epidermal growth factor in NRK fibroblasts"], "prefix": "10.1016", "volume": "36", "author": [{"given": "R", "family": "ASSOIAN", "sequence": "first", "affiliation": []}, {"given": "C", "family": "FROLIK", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "ROBERTS", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "MILLER", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "SPORN", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0092867484900710?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0092867484900710?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T23:27:42Z", "timestamp": 1549754862000}, "score": 26.95314, "issued": {"date-parts": [[1984, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1984, 1]]}, "issue": "1"}, "alternative-id": ["0092867484900710"], "URL": "http://dx.doi.org/10.1016/0092-8674(84)90071-0", "ISSN": ["0092-8674"], "issn-type": [{"value": "0092-8674", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:04:16Z", "timestamp": 1574168656635}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 10, 1]], "date-time": "2000-10-01T00:00:00Z", "timestamp": 970358400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Regulatory Peptides"], "published-print": {"date-parts": [[2000, 10]]}, "DOI": "10.1016/s0167-0115(00)80090-7", "type": "journal-article", "created": {"date-parts": [[2003, 7, 22]], "date-time": "2003-07-22T23:37:54Z", "timestamp": 1058917074000}, "page": "45", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Milk-borne epidermal growth factor reduces insulin-like growth factor-I mRNA levels in duodenum of developing rats"], "prefix": "10.1016", "volume": "94", "author": [{"given": "Bohuslav", "family": "Dvorak", "sequence": "first", "affiliation": []}, {"given": "Jessica A.", "family": "Dominguez", "sequence": "additional", "affiliation": []}, {"given": "Catherine S.", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "Debra L.", "family": "McWilliam", "sequence": "additional", "affiliation": []}, {"given": "Anthony F.", "family": "Phillips", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Regulatory Peptides"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0167011500800907?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0167011500800907?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T09:21:29Z", "timestamp": 1552814489000}, "score": 26.92748, "issued": {"date-parts": [[2000, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 10]]}, "issue": "1-3"}, "alternative-id": ["S0167011500800907"], "URL": "http://dx.doi.org/10.1016/s0167-0115(00)80090-7", "ISSN": ["0167-0115"], "issn-type": [{"value": "0167-0115", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:44:35Z", "timestamp": 1576781075164}, "reference-count": 48, "publisher": "Springer Science and Business Media LLC", "issue": "49", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 8, 30]], "date-time": "2010-08-30T00:00:00Z", "timestamp": 1283126400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1038/onc.2010.377", "type": "journal-article", "created": {"date-parts": [[2010, 8, 30]], "date-time": "2010-08-30T11:31:45Z", "timestamp": 1283167905000}, "page": "6485-6498", "source": "Crossref", "is-referenced-by-count": 127, "title": ["Transforming growth factor-\u03b2-induced epithelial\u2013mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression"], "prefix": "10.1038", "volume": "29", "author": [{"given": "M K", "family": "Wendt", "sequence": "first", "affiliation": []}, {"given": "J A", "family": "Smith", "sequence": "additional", "affiliation": []}, {"given": "W P", "family": "Schiemann", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 8, 30]]}, "reference": [{"key": "BFonc2010377_CR1", "first-page": "1399", "volume": "52", "author": "CJ Aslakson", "year": "1992", "unstructured": "Aslakson CJ, Miller FR . (1992). Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399\u20131405.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR2", "doi-asserted-by": "publisher", "first-page": "685", "DOI": "10.1007/s10585-007-9121-7", "volume": "25", "author": "S Barr", "year": "2008", "unstructured": "Barr S, Thomson S, Buck E, Russo S, Petti F, Sujka-Kwok I et al. (2008). Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis 25: 685\u2013693.", "journal-title": "Clin Exp Metastasis"}, {"key": "BFonc2010377_CR3", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1158/0008-5472.CAN-07-1588", "volume": "68", "author": "A Bremm", "year": "2008", "unstructured": "Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G et al. (2008). Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res 68: 707\u2013714.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR4", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1158/1535-7163.MCT-06-0462", "volume": "6", "author": "E Buck", "year": "2007", "unstructured": "Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D et al. (2007). Loss of homotypic cell adhesion by epithelial\u2013mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 6: 532\u2013541.", "journal-title": "Mol Cancer Ther"}, {"key": "BFonc2010377_CR5", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/j.yexcr.2007.09.005", "volume": "314", "author": "C Cicchini", "year": "2008", "unstructured": "Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A et al. (2008). TGF-\u03b2-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314: 143\u2013152.", "journal-title": "Exp Cell Res"}, {"key": "BFonc2010377_CR6", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1007/s10911-007-9041-9", "volume": "12", "author": "P Cowin", "year": "2007", "unstructured": "Cowin P, Welch DR . (2007). Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. J Mammary Gland Biol Neoplasia 12: 99\u2013102.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "BFonc2010377_CR7", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1016/j.ccr.2009.06.018", "volume": "16", "author": "DG DeNardo", "year": "2009", "unstructured": "DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N et al. (2009). CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16: 91\u2013102.", "journal-title": "Cancer Cell"}, {"key": "BFonc2010377_CR8", "doi-asserted-by": "publisher", "first-page": "2907", "DOI": "10.1210/me.2007-0293", "volume": "21", "author": "A Dhasarathy", "year": "2007", "unstructured": "Dhasarathy A, Kajita M, Wade PA . (2007). The transcription factor Snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor \u03b1. Mol Endocrinol 21: 2907\u20132918.", "journal-title": "Mol Endocrinol"}, {"key": "BFonc2010377_CR9", "doi-asserted-by": "publisher", "first-page": "26839", "DOI": "10.1074/jbc.M803645200", "volume": "283", "author": "Q Ding", "year": "2008", "unstructured": "Ding Q, Gladson CL, Wu H, Hayasaka H, Olman MA . (2008). FAK-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem 283: 26839\u201326849.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010377_CR10", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1007/s000180050498", "volume": "57", "author": "P Friedl", "year": "2000", "unstructured": "Friedl P, Brocker EB . (2000). The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 57: 41\u201364.", "journal-title": "Cell Mol Life Sci"}, {"key": "BFonc2010377_CR11", "doi-asserted-by": "publisher", "first-page": "R42", "DOI": "10.1186/bcr1524", "volume": "8", "author": "AJ Galliher", "year": "2006", "unstructured": "Galliher AJ, Schiemann WP . (2006). \u03b23 integrin and Src facilitate TGF-\u03b2 mediated induction of epithelial\u2013mesenchymal transition in mammary epithelial cells. Breast Cancer Res 8: R42.", "journal-title": "Breast Cancer Res"}, {"key": "BFonc2010377_CR12", "doi-asserted-by": "publisher", "first-page": "3752", "DOI": "10.1158/0008-5472.CAN-06-3851", "volume": "67", "author": "AJ Galliher", "year": "2007", "unstructured": "Galliher AJ, Schiemann WP . (2007). Src phosphorylates Tyr284 in TGF-\u03b2 type II receptor and regulates TGF-\u03b2 stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752\u20133758.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR13", "doi-asserted-by": "publisher", "first-page": "374", "DOI": "10.1002/jcp.21223", "volume": "213", "author": "H Hugo", "year": "2007", "unstructured": "Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. (2007). Epithelial\u2013mesenchymal and mesenchymal\u2013epithelial transitions in carcinoma progression. J Cell Physiol 213: 374\u2013383.", "journal-title": "J Cell Physiol"}, {"key": "BFonc2010377_CR14", "doi-asserted-by": "publisher", "first-page": "614", "DOI": "10.1038/sj.onc.1210649", "volume": "27", "author": "CK Joo", "year": "2007", "unstructured": "Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT . (2007). Ligand release-independent transactivation of epidermal growth factor receptor by TGF-\u03b2 involves multiple signaling pathways. Oncogene 27: 614\u2013628.", "journal-title": "Oncogene"}, {"key": "BFonc2010377_CR15", "doi-asserted-by": "publisher", "first-page": "1420", "DOI": "10.1172/JCI39104", "volume": "119", "author": "R Kalluri", "year": "2009", "unstructured": "Kalluri R, Weinberg RA . (2009). The basics of epithelial\u2013mesenchymal transition. J Clin Invest 119: 1420\u20131428.", "journal-title": "J Clin Invest"}, {"key": "BFonc2010377_CR16", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1016/j.molonc.2007.02.004", "volume": "1", "author": "PA Kenny", "year": "2007", "unstructured": "Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT et al. (2007). The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1: 84\u201396.", "journal-title": "Mol Oncol"}, {"key": "BFonc2010377_CR17", "doi-asserted-by": "publisher", "first-page": "2678", "DOI": "10.1172/JCI37815", "volume": "119", "author": "DS Micalizzi", "year": "2009", "unstructured": "Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Baron AE, Harrell JC et al. (2009). The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial\u2013mesenchymal transition and metastasis in mice through increasing TGF-\u03b2 signaling. J Clin Invest 119: 2678\u20132690.", "journal-title": "J Clin Invest"}, {"key": "BFonc2010377_CR18", "doi-asserted-by": "publisher", "first-page": "2021", "DOI": "10.1083/jcb.127.6.2021", "volume": "127", "author": "PJ Miettinen", "year": "1994", "unstructured": "Miettinen PJ, Ebner R, Lopez AR, Derynck R . (1994). TGF-\u03b2 induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127: 2021\u20132036.", "journal-title": "J Cell Biol"}, {"key": "BFonc2010377_CR19", "doi-asserted-by": "publisher", "first-page": "4429", "DOI": "10.1038/sj.onc.1209482", "volume": "25", "author": "SK Mitra", "year": "2006", "unstructured": "Mitra SK, Lim ST, Chi A, Schlaepfer DD . (2006). Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 25: 4429\u20134440.", "journal-title": "Oncogene"}, {"key": "BFonc2010377_CR20", "doi-asserted-by": "publisher", "first-page": "1512", "DOI": "10.1111/j.1349-7006.2007.00550.x", "volume": "98", "author": "A Moustakas", "year": "2007", "unstructured": "Moustakas A, Heldin CH . (2007). Signaling networks guiding epithelial\u2013mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512\u20131520.", "journal-title": "Cancer Sci"}, {"key": "BFonc2010377_CR21", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1016/j.cell.2008.01.046", "volume": "133", "author": "D Padua", "year": "2008", "unstructured": "Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR et al. (2008). TGF-\u03b2 primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66\u201377.", "journal-title": "Cell"}, {"key": "BFonc2010377_CR22", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1016/S1357-4310(00)01756-1", "volume": "6", "author": "CC Park", "year": "2000", "unstructured": "Park CC, Bissell MJ, Barcellos-Hoff MH . (2000). The influence of the microenvironment on the malignant phenotype. Mol Med Today 6: 324\u2013329.", "journal-title": "Mol Med Today"}, {"key": "BFonc2010377_CR23", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747\u2013752.", "journal-title": "Nature"}, {"key": "BFonc2010377_CR24", "doi-asserted-by": "publisher", "first-page": "1935", "DOI": "10.1158/0008-5472.CAN-07-5155", "volume": "68", "author": "WG Roberts", "year": "2008", "unstructured": "Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C et al. (2008). Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68: 1935\u20131944.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR25", "doi-asserted-by": "publisher", "first-page": "508", "DOI": "10.1038/sj.neo.7900051", "volume": "1", "author": "D Saha", "year": "1999", "unstructured": "Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL et al. (1999). Synergistic induction of cyclooxygenase-2 by TGF-\u03b21 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia 1: 508\u2013517.", "journal-title": "Neoplasia"}, {"key": "BFonc2010377_CR26", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1002/jcp.1041300313", "volume": "130", "author": "DS Salomon", "year": "1987", "unstructured": "Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R . (1987). Loss of growth responsiveness to epidermal growth factor and enhanced production of \u03b1-transforming growth factors in Ras-transformed mouse mammary epithelial cells. J Cell Physiol 130: 397\u2013409.", "journal-title": "J Cell Physiol"}, {"key": "BFonc2010377_CR27", "doi-asserted-by": "publisher", "first-page": "10290", "DOI": "10.1073/pnas.0904227106", "volume": "106", "author": "T Shibue", "year": "2009", "unstructured": "Shibue T, Weinberg RA . (2009). Integrin \u03b21-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106: 10290\u201310295.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010377_CR28", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1038/35010517", "volume": "2", "author": "DJ Sieg", "year": "2000", "unstructured": "Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH et al. (2000). FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249\u2013256.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2010377_CR29", "doi-asserted-by": "publisher", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "T Sorlie", "year": "2001", "unstructured": "Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869\u201310874.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010377_CR30", "doi-asserted-by": "publisher", "first-page": "8418", "DOI": "10.1073/pnas.0932692100", "volume": "100", "author": "T Sorlie", "year": "2003", "unstructured": "Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418\u20138423.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2010377_CR31", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1006/excr.1996.0221", "volume": "226", "author": "K Takahashi", "year": "1996", "unstructured": "Takahashi K, Suzuki K . (1996). Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell\u2013cell adhesion. Exp Cell Res 226: 214\u2013222.", "journal-title": "Exp Cell Res"}, {"key": "BFonc2010377_CR32", "doi-asserted-by": "publisher", "first-page": "5996", "DOI": "10.1158/0008-5472.CAN-05-0699", "volume": "65", "author": "D Tarin", "year": "2005", "unstructured": "Tarin D, Thompson EW, Newgreen DF . (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65: 5996\u20136000.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR33", "doi-asserted-by": "publisher", "first-page": "871", "DOI": "10.1016/j.cell.2009.11.007", "volume": "139", "author": "JP Thiery", "year": "2009", "unstructured": "Thiery JP, Acloque H, Huang RY, Nieto MA . (2009). Epithelial\u2013mesenchymal transitions in development and disease. Cell 139: 871\u2013890.", "journal-title": "Cell"}, {"key": "BFonc2010377_CR34", "doi-asserted-by": "publisher", "first-page": "9455", "DOI": "10.1158/0008-5472.CAN-05-1058", "volume": "65", "author": "S Thomson", "year": "2005", "unstructured": "Thomson S, Buck E, Petti F, Griffin G, Brown E, Ramnarine N et al. (2005). Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65: 9455\u20139462.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR35", "doi-asserted-by": "publisher", "first-page": "843", "DOI": "10.1007/s10585-008-9200-4", "volume": "25", "author": "S Thomson", "year": "2008", "unstructured": "Thomson S, Petti F, Sujka-Kwok I, Epstein D, Haley JD . (2008). Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis 25: 843\u2013854.", "journal-title": "Clin Exp Metastasis"}, {"key": "BFonc2010377_CR36", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.2217/14796694.5.2.259", "volume": "5", "author": "M Tian", "year": "2009", "unstructured": "Tian M, Schiemann WP . (2009). The TGF-\u03b2 paradox in human cancer: an update. Future Oncol 5: 259\u2013271.", "journal-title": "Future Oncol"}, {"key": "BFonc2010377_CR37", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1186/1471-2407-7-134", "volume": "7", "author": "M Tischkowitz", "year": "2007", "unstructured": "Tischkowitz M, Brunet J-S, Begin L, Huntsman D, Cheang M, Akslen L et al. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 7: 134.", "journal-title": "BMC Cancer"}, {"key": "BFonc2010377_CR38", "doi-asserted-by": "publisher", "first-page": "5605", "DOI": "10.1128/MCB.00787-08", "volume": "28", "author": "SE Wang", "year": "2008", "unstructured": "Wang SE, Xiang B, Guix M, Olivares MG, Parker J, Chung CH et al. (2008). TGF-\u03b2 engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to Trastuzumab. Mol Cell Biol 28: 5605\u20135620.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2010377_CR39", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1158/0008-5472.CAN-08-2649", "volume": "69", "author": "SE Wang", "year": "2009", "unstructured": "Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A, Arteaga CL . (2009). TGF-\u03b2 induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res 69: 475\u2013482.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR40", "doi-asserted-by": "publisher", "first-page": "R68", "DOI": "10.1186/bcr2360", "volume": "11", "author": "M Wendt", "year": "2009", "unstructured": "Wendt M, Schiemann W . (2009). Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-\u03b2 signaling and metastasis. Breast Cancer Res 11: R68.", "journal-title": "Breast Cancer Res"}, {"key": "BFonc2010377_CR41", "doi-asserted-by": "publisher", "first-page": "1145", "DOI": "10.2217/fon.09.90", "volume": "5", "author": "MK Wendt", "year": "2009", "unstructured": "Wendt MK, Allington TM, Schiemann WP . (2009a). Mechanisms of the epithelial\u2013mesenchymal transition by TGF-\u03b2. Future Oncol 5: 1145\u20131168.", "journal-title": "Future Oncol"}, {"key": "BFonc2010377_CR42", "doi-asserted-by": "publisher", "first-page": "1461", "DOI": "10.1038/sj.onc.1210751", "volume": "27", "author": "MK Wendt", "year": "2008", "unstructured": "Wendt MK, Cooper AN, Dwinell MB . (2008). Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 27: 1461\u20131471.", "journal-title": "Oncogene"}, {"key": "BFonc2010377_CR43", "doi-asserted-by": "publisher", "first-page": "34145", "DOI": "10.1074/jbc.M109.023614", "volume": "284", "author": "MK Wendt", "year": "2009", "unstructured": "Wendt MK, Smith JA, Schiemann WP . (2009b). p130Cas is required for mammary tumor growth and transforming growth factor-beta (TGF-beta)-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem 284: 34145\u201334156.", "journal-title": "J Biol Chem"}, {"key": "BFonc2010377_CR44", "first-page": "5285", "volume": "56", "author": "J Wilding", "year": "1996", "unstructured": "Wilding J, Vousden KH, Soutter WP, McCrea PD, Del Buono R, Pignatelli M . (1996). E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected deratinocytes. Cancer Res 56: 5285\u20135292.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR45", "doi-asserted-by": "publisher", "first-page": "7022", "DOI": "10.1158/0008-5472.CAN-04-1449", "volume": "64", "author": "J Wyckoff", "year": "2004", "unstructured": "Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER et al. (2004). A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022\u20137029.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR46", "first-page": "5401", "volume": "60", "author": "JB Wyckoff", "year": "2000", "unstructured": "Wyckoff JB, Segall JE, Condeelis JS . (2000). The collection of the motile population of cells from a living tumor. Cancer Res 60: 5401\u20135404.", "journal-title": "Cancer Res"}, {"key": "BFonc2010377_CR47", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1016/j.devcel.2008.05.009", "volume": "14", "author": "J Yang", "year": "2008", "unstructured": "Yang J, Weinberg RA . (2008). Epithelial\u2013mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818\u2013829.", "journal-title": "Dev Cell"}, {"key": "BFonc2010377_CR48", "doi-asserted-by": "publisher", "first-page": "5764", "DOI": "10.1038/sj.onc.1208927", "volume": "24", "author": "J Zavadil", "year": "2005", "unstructured": "Zavadil J, Bottinger EP . (2005). TGF-\u03b2 and epithelial-to-mesenchymal transitions. Oncogene 24: 5764\u20135774.", "journal-title": "Oncogene"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2010377.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010377", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2010377.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T16:30:04Z", "timestamp": 1555605004000}, "score": 26.88914, "issued": {"date-parts": [[2010, 8, 30]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "49"}, "alternative-id": ["BFonc2010377"], "URL": "http://dx.doi.org/10.1038/onc.2010.377", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:27:46Z", "timestamp": 1574112466009}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1023/a:1006194700667", "type": "journal-article", "created": {"date-parts": [[2002, 12, 22]], "date-time": "2002-12-22T00:53:09Z", "timestamp": 1040518389000}, "page": "167-176", "source": "Crossref", "is-referenced-by-count": 64, "title": ["Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas"], "prefix": "10.1007", "volume": "53", "author": [{"given": "Rosemary A.", "family": "Walker", "sequence": "first", "affiliation": []}, {"given": "Sheila J.", "family": "Dearing", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "194277_CR1", "first-page": "11489", "volume": "257", "author": "MN Krupp", "year": "1982", "unstructured": "Krupp MN, Connolly DT, Lane MD: Synthesis, turnover and down-regulation of epidermal growth factor receptors in human A431 epidermal carcinoma cells and skin fibroblasts. J Biol Chem 257: 11489\u201311496, 1982", "journal-title": "J Biol Chem"}, {"key": "194277_CR2", "first-page": "831", "volume": "4", "author": "R Di Marco", "year": "1990", "unstructured": "Di Marco R, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP: Autocrine interaction between TGF a and EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831\u2013839, 1990", "journal-title": "Oncogene"}, {"key": "194277_CR3", "doi-asserted-by": "crossref", "first-page": "596", "DOI": "10.1210/endo-126-1-596", "volume": "126", "author": "SE Bates", "year": "1990", "unstructured": "Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME, Dickson RB: Expression of the transforming growth factor-\u03b1/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinol 126: 596\u2013607, 1990", "journal-title": "Endocrinol"}, {"key": "194277_CR4", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1038/bjc.1989.338", "volume": "60", "author": "S Barker", "year": "1989", "unstructured": "Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP: Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer 60: 673\u2013677, 1989", "journal-title": "Br J Cancer"}, {"key": "194277_CR5", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1038/bjc.1993.2", "volume": "67", "author": "R Dittadi", "year": "1993", "unstructured": "Dittadi R, Donisi PM, Brazzale A, Capellozza L, Bruscagnin G, Gion M: Epidermal growth factor receptor in breast cancer.Comparison with non-malignant breast tissue. Br J Cancer 67: 7\u20139, 1993", "journal-title": "Br J Cancer"}, {"key": "194277_CR6", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1016/0046-8177(90)90035-4", "volume": "21", "author": "Y Tsutsumi", "year": "1990", "unstructured": "Tsutsumi Y, Naber SP, DeLellis RA, Wolfe HJ, Marks PJ, McKenzie SJ, Yin S: Neu oncogene and epidermal growth factor receptor are independently expressed in benign and malignant tissues. Hum Pathol 21: 750\u2013758, 1990", "journal-title": "Hum Pathol"}, {"key": "194277_CR7", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/0960-9776(92)90142-O", "volume": "2", "author": "RA Walker", "year": "1992", "unstructured": "Walker RA, Cowl J, Dhadly PP, Jones JL: Oestrogen receptor, epidermal growth factor receptor and oncoprotein expression in non-involved tissue of cancerous breasts. Breast 2: 87\u201391, 1992", "journal-title": "Breast"}, {"key": "194277_CR8", "first-page": "1238", "volume": "144", "author": "T van Agthoven", "year": "1994", "unstructured": "van Agthoven T, Timmermans M, Foekens JA, Dorssers LCJ, Henzen-Logmans SC: Differential expression of oestrogen, progesterone and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 144: 1238\u20131246, 1994", "journal-title": "Am J Pathol"}, {"key": "194277_CR9", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1007/BF01806677", "volume": "38", "author": "A Gompel", "year": "1996", "unstructured": "Gompel A, Martin A, Simon P, Schoevaert D, Plu-Bureau G, Hugol D, Andouin J, Leygue E, Truc JB, Poitout PL: Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle. Breast Cancer Res Treat 38: 227\u2013235, 1996", "journal-title": "Breast Cancer Res Treat"}, {"key": "194277_CR10", "first-page": "3", "volume": "13", "author": "JGM Klijn", "year": "1992", "unstructured": "Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA: The clinical significance of epidermal growth factor in human breast cancer. A review on 5232 patients. Endocr Rev 13: 3\u201317, 1992", "journal-title": "Endocr Rev"}, {"key": "194277_CR11", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1016/S0140-6736(85)91385-6", "volume": "i", "author": "JRC Sainsbury", "year": "1985", "unstructured": "Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL: Epidermal growth factor receptor in human breast cancer. Lancet i: 364\u2013366, 1985", "journal-title": "Lancet"}, {"key": "194277_CR12", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1002/path.1711500107", "volume": "150", "author": "RA Walker", "year": "1986", "unstructured": "Walker RA, Camplejohn RS: DNA flow cytometry of human breast carcinomas and its relationship to transferring and epidermal growth factor receptors. J Pathol 150: 37\u201342, 1986", "journal-title": "J Pathol"}, {"key": "194277_CR13", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1016/S0959-8049(05)80215-1", "volume": "29A", "author": "RI Nicholson", "year": "1993", "unstructured": "Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WL, Dixon AR, Robertson JFR, Ellis IO, Blamey RW: Relationship between EGF-R, c-erbB-2 protein expression and Ki 67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29A: 1018\u20131023, 1993", "journal-title": "Eur J Cancer"}, {"key": "194277_CR14", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1007/BF00666187", "volume": "29", "author": "RI Nicholson", "year": "1994", "unstructured": "Nicholson RI, McClelland RA, Gee JMW, Manning DL, Cannon P, Robertson JFR, Ellis IO, Blamey RW: Epidermal growth factor receptor expression in breast cancer: association with responses to endocrine therapy. Breast Cancer Res Treat 29: 117\u2013125, 1994", "journal-title": "Breast Cancer Res Treat"}, {"key": "194277_CR15", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1016/S0140-6736(89)91202-6", "volume": "i", "author": "S Nicholson", "year": "1989", "unstructured": "Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL: Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet i: 182\u2013184, 1989", "journal-title": "Lancet"}, {"key": "194277_CR16", "first-page": "1398", "volume": "i", "author": "JRC Sainsbury", "year": "1987", "unstructured": "Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet i: 1398\u20131402, 1987", "journal-title": "Lancet"}, {"key": "194277_CR17", "first-page": "4544", "volume": "51", "author": "PG Koenders", "year": "1981", "unstructured": "Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CMB, Benraad TJ: Epidermal growth factor receptor negative tumours are predominantly confined to the subgroup of oestradiol receptor positive human primary breast cancers. Cancer Res 51: 4544\u20134548, 1981", "journal-title": "Cancer Res"}, {"key": "194277_CR18", "first-page": "1023", "volume": "28A", "author": "M Bilous", "year": "1992", "unstructured": "Bilous M, Milliken J, Mathijs J-M: Immunocytochemistry and in situ hybridization of epidermal growth factor receptor and relation to prognostic factors in breast cancer. Eur J Cancer 28A: 1023\u20131038, 1992", "journal-title": "ur J Cancer"}, {"key": "194277_CR19", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1210/mend-1-3-216", "volume": "1", "author": "NE Davidson", "year": "1987", "unstructured": "Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor gene expression in estrogen receptor positive and negative human breast cancer cell lines. Mol Endocrinol 1: 216\u2013233, 1987", "journal-title": "Mol Endocrinol"}, {"key": "194277_CR20", "doi-asserted-by": "crossref", "first-page": "1621", "DOI": "10.1136/bmj.296.6637.1621", "volume": "296", "author": "MT Travers", "year": "1988", "unstructured": "Travers MT, Barrett-Lee PJ, Berger U, Luqmani YA, Gazet JC, Powles TJ, Coombes RC: Growth factor expression in normal, benign and malignant breast tissue. Br Med J 296: 1621\u20131624, 1988", "journal-title": "Br Med J"}, {"key": "194277_CR21", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1111/j.1365-2559.1991.tb00229.x", "volume": "19", "author": "CW Elston", "year": "1991", "unstructured": "Elston CW, Ellis IO: Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathol 19: 403\u2013410, 1991", "journal-title": "Histopathol"}, {"key": "194277_CR22", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1002/jcb.240200207", "volume": "20", "author": "MD Waterfield", "year": "1982", "unstructured": "Waterfield MD, Mayes ELV, Stroobaut P, Bennett PLP, Young S, Goodfellow RN, Banting GS, Ozanne B: A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20: 149\u2013161, 1982", "journal-title": "J Cell Biochem"}, {"key": "194277_CR23", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1038/bjc.1995.31", "volume": "71", "author": "R Rajakariar", "year": "1995", "unstructured": "Rajakariar R, Walker RA: Pathological and biological features of mammographically detected invasive breast carcinomas. Br J Cancer 71: 150\u2013154, 1995", "journal-title": "Br J Cancer"}, {"key": "194277_CR24", "doi-asserted-by": "crossref", "first-page": "1237", "DOI": "10.1038/bjc.1996.522", "volume": "74", "author": "JL Jones", "year": "1996", "unstructured": "Jones JL, Royall JE, Walker RA: E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237\u20131241, 1996", "journal-title": "Br J Cancer"}, {"key": "194277_CR25", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1038/309418a0", "volume": "309", "author": "A Ullrich", "year": "1984", "unstructured": "Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlesinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermal carcinoma cells. Nature 309: 418\u2013425, 1984", "journal-title": "Nature"}, {"key": "194277_CR26", "author": "JH Pringle", "first-page": "85", "year": "1995", "unstructured": "Pringle JH: Non-isotopic detection of RNA in situ. In: Levy ER, Herrington CS (eds) Non-isotopic Methods in Molecular Biology. IRL, Oxford, 1995, pp 85\u2013110", "volume-title": "Non-isotopic Methods in Molecular Biology"}, {"key": "194277_CR27", "first-page": "24A", "volume": "178", "author": "HI Hassan", "year": "1996", "unstructured": "Hassan HI, Walker RA: Comparison of epidermal growth factor expression in non-involved tissue of cancercontaining breast with normal/benign breast. J Pathol 178: 24A, 1996", "journal-title": "J Pathol"}, {"key": "194277_CR28", "first-page": "161", "volume": "48", "author": "J Ro", "year": "1988", "unstructured": "Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M: Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinomas. Cancer Res 48: 161\u2013164, 1988", "journal-title": "Cancer Res"}, {"key": "194277_CR29", "doi-asserted-by": "crossref", "first-page": "1408", "DOI": "10.1038/bjc.1993.261", "volume": "67", "author": "PA Murray", "year": "1993", "unstructured": "Murray PA, Barrett-Lee P, Travers M, L uqmani Y, Powles T, Coombes RC: The prognostic significance of transforming growth factors in human breast cancer. Br J Cancer 67: 1408\u20131413, 1993", "journal-title": "Br J Cancer"}, {"key": "194277_CR30", "first-page": "728", "volume": "46", "author": "LJ Murphy", "year": "1986", "unstructured": "Murphy LJ, Sutherland RL, Murphy LC, Lazarus L: Progesterone regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res 46: 728\u2013734, 1986", "journal-title": "Cancer Res"}, {"key": "194277_CR31", "doi-asserted-by": "crossref", "first-page": "744", "DOI": "10.1002/ijc.2910440432", "volume": "44", "author": "TM Ewing", "year": "1989", "unstructured": "Ewing TM, Murphy LJ, Ng M-L, Pang GYN, Lee CSL, Watts CKW, Sutherland RL: Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Int J Cancer 44: 744\u2013752, 1989", "journal-title": "Int J Cancer"}, {"key": "194277_CR32", "doi-asserted-by": "crossref", "first-page": "2739", "DOI": "10.1210/endo.137.7.8770893", "volume": "137", "author": "RI Yarden", "year": "1996", "unstructured": "Yarden RI, Lauber AH, EI Ashry D, Chrysogelos SA: Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinol 137: 2739\u20132747, 1996", "journal-title": "Endocrinol"}, {"key": "194277_CR33", "first-page": "903", "volume": "8", "author": "A de Fazio", "year": "1997", "unstructured": "de Fazio A, Chiew YE, McEvoy M, Watts CKW, Sutherland RL: Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. Cell Growth Different 8: 903\u2013911, 1997", "journal-title": "Cell Growth Different"}, {"key": "194277_CR34", "doi-asserted-by": "crossref", "first-page": "712", "DOI": "10.1002/ijc.2910460427", "volume": "46", "author": "EM Valverius", "year": "1990", "unstructured": "Valverius EM, Velu T, Shankar V, Ciardiello F, Kim N, Salomon DS: Overexpression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer 46: 712\u2013718, 1990", "journal-title": "Int J Cancer"}, {"key": "194277_CR35", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1007/BF00666156", "volume": "31", "author": "SA Chrysogelos", "year": "1994", "unstructured": "Chrysogelos SA, Yardin RI, Lauber AH, Murphy JM: Mechanisms of EGF receptor regulation in breast cancer cells. Breast Cancer Res Treat 31: 227\u2013236, 1994", "journal-title": "Breast Cancer Res Treat"}, {"key": "194277_CR36", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1006/excr.1997.3662", "volume": "235", "author": "JL Jones", "year": "1997", "unstructured": "Jones JL, Royall JE, Critchley DR, Walker RA: Modulation of myoepithelial-associated a6b4 integrin in a breast cancer cell line alters invasive potential. Exp Cell Res 235: 325\u2013333, 1997", "journal-title": "Exp Cell Res"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1023/A:1006194700667", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 5]], "date-time": "2017-11-05T01:05:57Z", "timestamp": 1509843957000}, "score": 26.706875, "issued": {"date-parts": [[1999, 1]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "2"}, "alternative-id": ["194277"], "URL": "http://dx.doi.org/10.1023/a:1006194700667", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:11:34Z", "timestamp": 1574485894043}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 1, 1]], "date-time": "2011-01-01T00:00:00Z", "timestamp": 1293840000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bone"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1016/j.bone.2010.10.147", "type": "journal-article", "created": {"date-parts": [[2010, 12, 22]], "date-time": "2010-12-22T10:00:37Z", "timestamp": 1293012037000}, "page": "S51-S52", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Breast cancer cell epidermal growth factor receptor signaling and osteolysis"], "prefix": "10.1016", "volume": "48", "author": [{"given": "N.K.", "family": "Nickerson*", "sequence": "first", "affiliation": []}, {"given": "J.L.", "family": "Gilmore", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Robling", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Foley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bone"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S875632821001851X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S875632821001851X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 6]], "date-time": "2018-12-06T04:21:11Z", "timestamp": 1544070071000}, "score": 26.627287, "issued": {"date-parts": [[2011, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "alternative-id": ["S875632821001851X"], "URL": "http://dx.doi.org/10.1016/j.bone.2010.10.147", "ISSN": ["8756-3282"], "issn-type": [{"value": "8756-3282", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:08:14Z", "timestamp": 1574287694970}, "reference-count": 42, "publisher": "Springer Science and Business Media LLC", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Res"], "published-print": {"date-parts": [[2000, 2]]}, "DOI": "10.1203/00006450-200002000-00008", "type": "journal-article", "created": {"date-parts": [[2007, 4, 13]], "date-time": "2007-04-13T10:04:04Z", "timestamp": 1176458644000}, "page": "194-194", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Milk-Borne Epidermal Growth Factor Modulates Intestinal Transforming Growth Factor-\u03b1 Levels in Neonatal Rats"], "prefix": "10.1038", "volume": "47", "author": [{"given": "Bohuslav", "family": "Dvorak", "sequence": "first", "affiliation": []}, {"given": "Catherine S", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "Debra L", "family": "McWilliam", "sequence": "additional", "affiliation": []}, {"given": "Hisae", "family": "Shinohara", "sequence": "additional", "affiliation": []}, {"given": "Jessica A", "family": "Dominguez", "sequence": "additional", "affiliation": []}, {"given": "Robert S", "family": "McCuskey", "sequence": "additional", "affiliation": []}, {"given": "Anthony F", "family": "Philipps", "sequence": "additional", "affiliation": []}, {"given": "Otakar", "family": "Koldovsky", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "pr200035-bib1", "unstructured": ""}, {"key": "pr200035-bib2", "author": "Weaver LT", "volume": "94", "first-page": "845", "year": "1988", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(88)90263-6", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib3", "author": "Weaver LT", "volume": "98", "first-page": "828", "year": "1990", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(90)90004-K", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib4", "author": "Opleta-Madsen K", "volume": "30", "first-page": "342", "year": "1991", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199110000-00010", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib5", "author": "Hardin JA", "volume": "39", "first-page": "169", "year": "1992", "journal-title": "Regul Pept", "DOI": "10.1016/0167-0115(92)90538-6", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib6", "author": "Barnard JA", "volume": "108", "first-page": "564", "year": "1995", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(95)90087-X", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib7", "author": "Polk DB", "volume": "114", "first-page": "493", "year": "1998", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(98)70532-3", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib8", "author": "Carpenter G", "volume": "80", "first-page": "5627", "year": "1983", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.80.18.5627", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib9", "author": "Todaro GJ", "volume": "77", "first-page": "5258", "year": "1980", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.77.9.5258", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib10", "author": "Rao RK", "volume": "250", "first-page": "G850", "year": "1986", "journal-title": "Am J Physiol"}, {"key": "pr200035-bib11", "author": "Thompson JF", "volume": "107", "first-page": "1278", "year": "1994", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(94)90528-2", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib12", "author": "Toyoda S", "volume": "886", "first-page": "295", "year": "1986", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/0167-4889(86)90148-5", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib13", "unstructured": ""}, {"key": "pr200035-bib14", "author": "Koldovsky O", "volume": "54", "first-page": "105", "year": "1996", "journal-title": "Ann Nestl"}, {"key": "pr200035-bib15", "author": "Grimes J", "volume": "199", "first-page": "75", "year": "1992", "journal-title": "Proc Soc Exp Biol Med", "DOI": "10.3181/00379727-199-43332", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib16", "author": "Schaudies RP", "volume": "256", "first-page": "G856", "year": "1989", "journal-title": "Am J Physiol"}, {"key": "pr200035-bib17", "author": "Dvorak B", "volume": "35", "first-page": "348", "year": "1994", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199403000-00015", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib18", "author": "Philipps AF", "volume": "272", "first-page": "R1532", "year": "1997", "journal-title": "Am J Physiol", "DOI": "10.1152/ajpcell.1997.272.5.C1532", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib19", "author": "Staley MD", "volume": "44", "first-page": "512", "year": "1998", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199810000-00008", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib20", "author": "Schaudies RP", "volume": "259", "first-page": "G1056", "year": "1990", "journal-title": "Am J Physiol"}, {"key": "pr200035-bib21", "author": "Thornburg W", "volume": "246", "first-page": "G80", "year": "1984", "journal-title": "Am J Physiol"}, {"key": "pr200035-bib22", "author": "Rao RK", "volume": "17", "first-page": "414", "year": "1993", "journal-title": "J Pediatr Gastroenterol Nutr", "DOI": "10.1097/00005176-199311000-00014", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib23", "author": "Dvorak B", "volume": "46", "first-page": "183", "year": "1992", "journal-title": "Prostaglandins Leukot Essent Fatty Acids", "DOI": "10.1016/0952-3278(92)90068-T", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib24", "author": "Dvorak B", "volume": "437", "first-page": "119", "year": "1998", "journal-title": "FEBS Lett", "DOI": "10.1016/S0014-5793(98)01050-3", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib25", "author": "Burton K", "volume": "62", "first-page": "315", "year": "1956", "journal-title": "Biochem J", "DOI": "10.1042/bj0620315", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib26", "author": "Lowry OH", "volume": "193", "first-page": "265", "year": "1951", "journal-title": "J Biol Chem"}, {"key": "pr200035-bib27", "author": "Shinohara H", "volume": "39", "first-page": "281", "year": "1996", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-199602000-00016", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib28", "author": "Stahl GE", "volume": "12", "first-page": "485", "year": "1991", "journal-title": "J Pediatr Gastroenterol Nutr", "DOI": "10.1097/00005176-199105000-00013", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib29", "author": "Schindler AE", "volume": "21", "first-page": "1", "year": "1982", "journal-title": "Monogr Endocrinol", "DOI": "10.1007/978-3-642-81656-7_1", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib30", "author": "Barka T", "volume": "45", "first-page": "679", "year": "1978", "journal-title": "Mt Sinai J Med"}, {"key": "pr200035-bib31", "author": "Weaver LT", "volume": "98", "first-page": "828", "year": "1990", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(90)90004-K", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib32", "author": "Playford RJ", "volume": "38", "first-page": "303", "year": "1996", "journal-title": "Gut", "DOI": "10.1136/gut.38.3.303", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib33", "author": "Yagi H", "volume": "75", "first-page": "233", "year": "1986", "journal-title": "Acta Paediat Scand", "DOI": "10.1111/j.1651-2227.1986.tb10190.x", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib34", "author": "Patel SM", "volume": "122", "first-page": "412", "year": "1992", "journal-title": "J Nutr", "DOI": "10.1093/jn/122.3.412", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib35", "author": "Patel SM", "volume": "14", "first-page": "21", "year": "1994", "journal-title": "Ann Rev Nutr", "DOI": "10.1146/annurev.nu.14.070194.000321", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib36", "author": "Dvorak B", "volume": "116", "first-page": "A547", "year": "1999", "journal-title": "Gastroenterology"}, {"key": "pr200035-bib37", "author": "Moore MC", "volume": "20", "first-page": "1248", "year": "1986", "journal-title": "Pediatr Res", "DOI": "10.1203/00006450-198612000-00012", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib38", "author": "Berseth CL", "volume": "253", "first-page": "G662", "year": "1987", "journal-title": "Am J Physiol", "DOI": "10.1152/ajpcell.1987.253.5.C662", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib39", "author": "O'Loughlin EV", "volume": "249", "first-page": "G674", "year": "1985", "journal-title": "Am J Physiol"}, {"key": "pr200035-bib40", "author": "Vinter-Jensen L", "volume": "61", "first-page": "135", "year": "1996", "journal-title": "Regul Pept", "DOI": "10.1016/0167-0115(95)00158-1", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib41", "author": "Dvorak B", "volume": "352", "first-page": "291", "year": "1994", "journal-title": "FEBS Lett", "DOI": "10.1016/0014-5793(94)00942-2", "doi-asserted-by": "crossref"}, {"key": "pr200035-bib42", "author": "Kong W", "volume": "102", "first-page": "661", "year": "1992", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(92)90117-H", "doi-asserted-by": "crossref"}], "container-title": ["Pediatric Research"], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T08:58:26Z", "timestamp": 1556355506000}, "score": 26.46054, "issued": {"date-parts": [[2000, 2]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2000, 2]]}, "issue": "2"}, "alternative-id": ["pr200035"], "URL": "http://dx.doi.org/10.1203/00006450-200002000-00008", "relation": {"cites": []}, "ISSN": ["0031-3998", "1530-0447"], "issn-type": [{"value": "0031-3998", "type": "print"}, {"value": "1530-0447", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:50:19Z", "timestamp": 1574322619050}, "reference-count": 79, "publisher": "Wiley", "issue": "5_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JPEN J Parenter Enteral Nutr"], "published-print": {"date-parts": [[1999, 9]]}, "DOI": "10.1177/014860719902300521", "type": "journal-article", "created": {"date-parts": [[2009, 9, 15]], "date-time": "2009-09-15T19:14:54Z", "timestamp": 1253042094000}, "page": "S83-S88", "source": "Crossref", "is-referenced-by-count": 35, "title": ["Epidermal Growth Factor, Epidermal Growth Factor Receptors, Intestinal Growth, and Adaptation"], "prefix": "10.1002", "volume": "23", "author": [{"given": "Wai-Man", "family": "Wong", "sequence": "first", "affiliation": []}, {"given": "Nicholas A.", "family": "Wright", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 11, 16]]}, "reference": [{"key": "atypb1", "volume": "40", "first-page": "35", "year": "1990", "journal-title": "Biochem Pharmacol", "DOI": "10.1016/0006-2952(90)90175-K", "doi-asserted-by": "crossref"}, {"key": "atypb2", "volume": "19", "first-page": "408", "year": "1978", "journal-title": "Gut", "DOI": "10.1136/gut.19.5.408", "doi-asserted-by": "crossref"}, {"key": "atypb3", "volume": "187", "first-page": "331", "year": "1999", "journal-title": "J Pathol", "DOI": "10.1002/(SICI)1096-9896(199902)187:3<331::AID-PATH241>3.0.CO;2-S", "doi-asserted-by": "crossref"}, {"key": "atypb4", "volume": "352", "first-page": "291", "year": "1994", "journal-title": "FEBS Lett", "DOI": "10.1016/0014-5793(94)00942-2", "doi-asserted-by": "crossref"}, {"key": "atypb5", "volume": "175", "first-page": "405", "year": "1995", "journal-title": "J Pathol", "DOI": "10.1002/path.1711750408", "doi-asserted-by": "crossref"}, {"key": "atypb6", "volume": "210", "first-page": "198", "year": "1980", "journal-title": "Science", "DOI": "10.1126/science.6968093", "doi-asserted-by": "crossref"}, {"key": "atypb7", "unstructured": "Carpenter G.: Epidermal growth factor. IN Tissue Growth Factors, Baserga R (ed). Springer-Verlag, Berlin, 1981, pp 89-123", "DOI": "10.1007/978-3-642-67986-5_3", "doi-asserted-by": "crossref"}, {"key": "atypb8", "volume": "37", "first-page": "404", "year": "1989", "journal-title": "Chem Pharm Bull", "DOI": "10.1248/cpb.37.404", "doi-asserted-by": "crossref"}, {"key": "atypb9", "volume": "108", "first-page": "92", "year": "1995", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(95)90012-8", "doi-asserted-by": "crossref"}, {"key": "atypb10", "volume": "341", "first-page": "843", "year": "1993", "journal-title": "Lancet", "DOI": "10.1016/0140-6736(93)93057-8", "doi-asserted-by": "crossref"}, {"key": "atypb11", "unstructured": "Goodlad RA, Wright NA: Quantitative studies on epithelial replacement in the gut. IN Techniques in the Life Sciences: Techniques in Digestive Physiology, Vol P2 . Titchen TA (ed). Elsevier Biomedical Press, Ireland, 1982, pp 212/1-212/21"}, {"key": "atypb12", "unstructured": "Goodlad RA: Microdissection-based techniques for the determination of cell proliferation in gastrointestinal epithelium: application to animal and human studies. IN Cell Biology: A Laboratory Handbook, Celis JE (ed). Academic Press, New York, 1994, pp 205-216"}, {"key": "atypb13", "volume": "98", "first-page": "267", "year": "1992", "journal-title": "Histochemistry", "DOI": "10.1007/BF00271041", "doi-asserted-by": "crossref"}, {"key": "atypb14", "volume": "326", "first-page": "515", "year": "1987", "journal-title": "Nature", "DOI": "10.1038/326515a0", "doi-asserted-by": "crossref"}, {"key": "atypb15", "volume": "326", "first-page": "517", "year": "1987", "journal-title": "Nature", "DOI": "10.1038/326517a0", "doi-asserted-by": "crossref"}, {"key": "atypb16", "volume": "95", "first-page": "1", "year": "1990", "journal-title": "J Cell Sci"}, {"key": "atypb17", "volume": "162", "first-page": "285", "year": "1990", "journal-title": "J Pathol", "DOI": "10.1002/path.1711620403", "doi-asserted-by": "crossref"}, {"key": "atypb18", "volume": "165", "first-page": "173", "year": "1991", "journal-title": "J Pathol", "DOI": "10.1002/path.1711650213", "doi-asserted-by": "crossref"}, {"key": "atypb19", "volume": "133", "first-page": "1710", "year": "1984", "journal-title": "J Immunol"}, {"key": "atypb20", "volume": "138", "first-page": "867", "year": "1991", "journal-title": "Am J Pathol"}, {"key": "atypb21", "volume": "22", "first-page": "355", "year": "1993", "journal-title": "Histopathology", "DOI": "10.1111/j.1365-2559.1993.tb00135.x", "doi-asserted-by": "crossref"}, {"key": "atypb22", "volume": "68", "first-page": "629", "year": "1993", "journal-title": "Lab Invest"}, {"key": "atypb23", "unstructured": "Goodlad RA, Wright NA: Epithelial kinetics; control and consequences of alteration in disease . IN Gastrointestinal and Oesophageal Pathology, 2nd ed, Whitehead R (ed). Churchill Livingstone, Edinburgh , 1995, pp 97-115"}, {"key": "atypb24", "volume": "101", "first-page": "1235", "year": "1991", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(91)90072-S", "doi-asserted-by": "crossref"}, {"key": "atypb25", "volume": "22", "first-page": "425", "year": "1989", "journal-title": "Cell Tissue Kinet"}, {"key": "atypb26", "volume": "41", "first-page": "1161", "year": "1985", "journal-title": "Experientia", "DOI": "10.1007/BF01951708", "doi-asserted-by": "crossref"}, {"key": "atypb27", "volume": "14", "first-page": "283", "year": "1990", "journal-title": "JPEN", "DOI": "10.1177/0148607190014003283", "doi-asserted-by": "crossref"}, {"key": "atypb28", "volume": "28", "first-page": "573", "year": "1987", "journal-title": "Gut", "DOI": "10.1136/gut.28.5.573", "doi-asserted-by": "crossref"}, {"key": "atypb29", "volume": "155", "first-page": "18", "year": "1988", "journal-title": "Am J Surg", "DOI": "10.1016/S0002-9610(88)80252-6", "doi-asserted-by": "crossref"}, {"key": "atypb30", "volume": "99", "first-page": "1710", "year": "1990", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(90)90477-I", "doi-asserted-by": "crossref"}, {"key": "atypb31", "volume": "28", "first-page": "511", "year": "1993", "journal-title": "Gastroenterol Jpn", "DOI": "10.1007/BF02776949", "doi-asserted-by": "crossref"}, {"key": "atypb32", "volume": "22", "first-page": "927", "year": "1981", "journal-title": "Gut", "DOI": "10.1136/gut.22.11.927", "doi-asserted-by": "crossref"}, {"key": "atypb33", "volume": "65", "first-page": "715", "year": "1992", "journal-title": "Yale J Biol Med"}, {"key": "atypb34", "volume": "325", "first-page": "35", "year": "1982", "journal-title": "J Physiol (Lond)", "DOI": "10.1113/jphysiol.1982.sp014133", "doi-asserted-by": "crossref"}, {"key": "atypb35", "volume": "91", "first-page": "1134", "year": "1986", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(86)80008-7", "doi-asserted-by": "crossref"}, {"key": "atypb36", "volume": "63", "first-page": "223", "year": "1991", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1991.53", "doi-asserted-by": "crossref"}, {"key": "atypb37", "volume": "253", "first-page": "G662", "year": "1987", "journal-title": "Am J Physiol", "DOI": "10.1152/ajpcell.1987.253.5.C662", "doi-asserted-by": "crossref"}, {"key": "atypb38", "volume": "90", "first-page": "427", "year": "1996", "journal-title": "Clin Sci (Colch)", "DOI": "10.1042/cs0900427", "doi-asserted-by": "crossref"}, {"key": "atypb39", "volume": "89", "first-page": "117", "year": "1995", "journal-title": "Clin Sci (Colch)", "DOI": "10.1042/cs0890117", "doi-asserted-by": "crossref"}, {"key": "atypb40", "volume": "152", "first-page": "1421", "year": "1988", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1016/S0006-291X(88)80444-3", "doi-asserted-by": "crossref"}, {"key": "atypb41", "volume": "265", "first-page": "G63", "year": "1993", "journal-title": "Am J Physiol"}, {"key": "atypb42", "year": "1984", "volume-title": "The Biology of Epithelial Cell Populations"}, {"key": "atypb43", "volume": "52", "first-page": "279", "year": "1987", "journal-title": "Biophys J", "DOI": "10.1016/S0006-3495(87)83215-0", "doi-asserted-by": "crossref"}, {"key": "atypb44", "volume": "151", "first-page": "843", "year": "1997", "journal-title": "Am J Pathol"}, {"key": "atypb45", "volume": "11", "first-page": "1239", "year": "1985", "journal-title": "Lancet"}, {"key": "atypb46", "volume": "27", "first-page": "1394", "year": "1986", "journal-title": "Gut", "DOI": "10.1136/gut.27.11.1394", "doi-asserted-by": "crossref"}, {"key": "atypb47", "volume": "338", "first-page": "53", "year": "1991", "journal-title": "Lancet"}, {"key": "atypb48", "volume": "264", "first-page": "1735", "year": "1989", "journal-title": "Biol Chem"}, {"key": "atypb49", "volume": "107", "first-page": "1278", "year": "1994", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(94)90528-2", "doi-asserted-by": "crossref"}, {"key": "atypb50", "volume": "19", "first-page": "307S", "year": "1991", "journal-title": "Biochem Soc Trans", "DOI": "10.1042/bst019307s", "doi-asserted-by": "crossref"}, {"key": "atypb51", "volume": "4", "first-page": "183", "year": "1992", "journal-title": "Reprod Fertil Dev", "DOI": "10.1071/RD9920183", "doi-asserted-by": "crossref"}, {"key": "atypb52", "volume": "23", "first-page": "57", "year": "1993", "journal-title": "Virchows Arch A Pathol Anat Histopathol"}, {"key": "atypb53", "volume": "101", "first-page": "640", "year": "1991", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(91)90520-U", "doi-asserted-by": "crossref"}, {"key": "atypb54", "volume": "39", "first-page": "262", "year": "1996", "journal-title": "Gut", "DOI": "10.1136/gut.39.2.262", "doi-asserted-by": "crossref"}, {"key": "atypb55", "volume": "254", "first-page": "G429", "year": "1988", "journal-title": "Am J Physiol"}, {"key": "atypb56", "volume": "246", "first-page": "G80", "year": "1984", "journal-title": "Am J Physiol"}, {"key": "atypb57", "volume": "80", "first-page": "22", "year": "1987", "journal-title": "J Clin Invest", "DOI": "10.1172/JCI113051", "doi-asserted-by": "crossref"}, {"key": "atypb58", "volume": "98", "first-page": "828", "year": "1990", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(90)90004-K", "doi-asserted-by": "crossref"}, {"key": "atypb59", "volume": "11", "first-page": "1093", "year": "1990", "journal-title": "Peptides", "DOI": "10.1016/0196-9781(90)90136-S", "doi-asserted-by": "crossref"}, {"key": "atypb60", "volume": "261", "first-page": "G790", "year": "1991", "journal-title": "Am J Physiol"}, {"key": "atypb61", "volume": "18", "first-page": "771", "year": "1983", "journal-title": "Scand J Gastroenterol", "DOI": "10.3109/00365528309182093", "doi-asserted-by": "crossref"}, {"key": "atypb62", "volume": "25", "first-page": "1234", "year": "1984", "journal-title": "Gut", "DOI": "10.1136/gut.25.11.1234", "doi-asserted-by": "crossref"}, {"key": "atypb63", "volume": "16", "first-page": "505", "year": "1995", "journal-title": "Peptides", "DOI": "10.1016/0196-9781(95)00002-2", "doi-asserted-by": "crossref"}, {"key": "atypb64", "volume": "19", "first-page": "495", "year": "1998", "journal-title": "Peptides", "DOI": "10.1016/S0196-9781(97)00462-2", "doi-asserted-by": "crossref"}, {"key": "atypb65", "volume": "3", "first-page": "343", "year": "1991", "journal-title": "Anal Cell Pathol"}, {"key": "atypb66", "volume": "49", "first-page": "157", "year": "1992", "journal-title": "Oncology", "DOI": "10.1159/000227031", "doi-asserted-by": "crossref"}, {"key": "atypb67", "volume": "3", "first-page": "2647", "year": "1989", "journal-title": "FASEB J", "DOI": "10.1096/fasebj.3.14.2556314", "doi-asserted-by": "crossref"}, {"key": "atypb68", "volume": "343", "first-page": "82", "year": "1990", "journal-title": "Nature", "DOI": "10.1038/343082a0", "doi-asserted-by": "crossref"}, {"key": "atypb69", "volume": "88", "first-page": "401", "year": "1995", "journal-title": "Clin Sci", "DOI": "10.1042/cs0880401", "doi-asserted-by": "crossref"}, {"key": "atypb70", "volume": "33", "first-page": "24", "year": "1998", "journal-title": "J Pediatr Surg", "DOI": "10.1016/S0022-3468(98)90354-2", "doi-asserted-by": "crossref"}, {"key": "atypb71", "volume": "58", "first-page": "565", "year": "1995", "journal-title": "J Surg Res", "DOI": "10.1006/jsre.1995.1089", "doi-asserted-by": "crossref"}, {"key": "atypb72", "volume": "31", "first-page": "56", "year": "1996", "journal-title": "J Pediatr Surg", "DOI": "10.1016/S0022-3468(96)90319-X", "doi-asserted-by": "crossref"}, {"key": "atypb73", "volume": "29", "first-page": "1035", "year": "1994", "journal-title": "J Pediatr Surg", "DOI": "10.1016/0022-3468(94)90274-7", "doi-asserted-by": "crossref"}, {"key": "atypb74", "volume": "122", "first-page": "721", "year": "1997", "journal-title": "Surgery", "DOI": "10.1016/S0039-6060(97)90079-9", "doi-asserted-by": "crossref"}, {"key": "atypb75", "volume": "67", "first-page": "90", "year": "1997", "journal-title": "J Surg Res", "DOI": "10.1006/jsre.1996.4959", "doi-asserted-by": "crossref"}, {"key": "atypb76", "volume": "107", "first-page": "87", "year": "1994", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(94)90064-7", "doi-asserted-by": "crossref"}, {"key": "atypb77", "volume": "33", "first-page": "229", "year": "1998", "journal-title": "Pediatr Surg", "DOI": "10.1016/S0022-3468(98)90437-7", "doi-asserted-by": "crossref"}, {"key": "atypb78", "volume": "56", "first-page": "180", "year": "1989", "journal-title": "Experientia Suppl", "DOI": "10.1007/978-3-0348-9136-3_10", "doi-asserted-by": "crossref"}, {"key": "atypb79", "volume": "32", "first-page": "1652", "year": "1997", "journal-title": "J Pediatr Surg", "DOI": "10.1016/S0022-3468(97)90476-0", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Parenteral and Enteral Nutrition"], "language": "en", "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1177/014860719902300521", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T16:07:42Z", "timestamp": 1558541262000}, "score": 26.080996, "issued": {"date-parts": [[1999, 9]]}, "references-count": 79, "journal-issue": {"published-online": {"date-parts": [[2016, 11, 16]]}, "published-print": {"date-parts": [[1999, 9]]}, "issue": "5_suppl"}, "alternative-id": ["10.1177/014860719902300521"], "URL": "http://dx.doi.org/10.1177/014860719902300521", "relation": {"cites": []}, "ISSN": ["0148-6071", "1941-2444"], "issn-type": [{"value": "0148-6071", "type": "print"}, {"value": "1941-2444", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T12:46:49Z", "timestamp": 1574426809681}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAMA"], "published-print": {"date-parts": [[1986, 6, 20]]}, "DOI": "10.1001/jama.1986.03370230076034", "type": "journal-article", "created": {"date-parts": [[2011, 11, 29]], "date-time": "2011-11-29T23:36:40Z", "timestamp": 1322609800000}, "page": "3270", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Breast Milk Jaundice in the Newborn"], "prefix": "10.1001", "volume": "255", "author": [{"given": "A. Patrick", "family": "Schneider", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["JAMA"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jama/fullarticle/404874", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T20:42:38Z", "timestamp": 1481834558000}, "score": 25.723078, "subtitle": ["A Real Entity"], "issued": {"date-parts": [[1986, 6, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1986, 6, 20]]}, "issue": "23"}, "URL": "http://dx.doi.org/10.1001/jama.1986.03370230076034", "ISSN": ["0098-7484"], "issn-type": [{"value": "0098-7484", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:19:33Z", "timestamp": 1574453973658}, "reference-count": 6, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3164, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1651-2227.2002.tb00142.x", "type": "journal-article", "created": {"date-parts": [[2010, 8, 7]], "date-time": "2010-08-07T05:22:07Z", "timestamp": 1281158527000}, "page": "1268-1269", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Hypernatraemic dehydration due to high sodium concentrations in breast milk: possible relationship with unwanted pregnancy"], "prefix": "10.1111", "volume": "91", "author": [{"given": "A", "family": "Kumral", "sequence": "first", "affiliation": []}, {"given": "N", "family": "Duman", "sequence": "additional", "affiliation": []}, {"given": "MM", "family": "Tatli", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Ozbek", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Demircioglu", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Ozkan", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 1, 2]]}, "reference": [{"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/S0031-3955(05)70296-0", "article-title": "Effects of stress on lactation", "volume": "48", "author": "Lau", "year": "2001", "journal-title": "Pediatr Clin North Am"}, {"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0031-3955(05)70284-4", "article-title": "Lactogenesis", "volume": "48", "author": "Neville", "year": "2001", "journal-title": "Pediatr Clin North Am"}, {"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1093/ajcn/58.1.54", "article-title": "Delayed lactogenesis in women with insulin-dependent diabetes mellitus", "volume": "58", "author": "Neubauer", "year": "1993", "journal-title": "Am J Clin Nutr"}, {"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB4|cit4", "first-page": "957", "article-title": "Increased incidence of severe breastfeeding malnutrition and hypernatremia in a metropolitan area", "volume": "96", "author": "Cooper", "year": "1995", "journal-title": "Pediatrics"}, {"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1375", "DOI": "10.1093/ajcn/48.6.1375", "article-title": "Studies in human lactation: milk volumes in lactating women during the onset of lactation and full lactation", "volume": "48", "author": "Neville", "year": "1988", "journal-title": "Am J Clin Nutr"}, {"key": "10.1111/j.1651-2227.2002.tb00142.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1677/joe.0.0550299", "article-title": "Central and peripheral neural influences on the oxytocin-induced pressure response of the mammary gland of the anesthetized lactating rat", "volume": "55", "author": "Grosvenor", "year": "1972", "journal-title": "J Endocrinol"}], "container-title": ["Acta Paediatrica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.2002.tb00142.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 3]], "date-time": "2019-03-03T06:59:02Z", "timestamp": 1551596342000}, "score": 25.63662, "issued": {"date-parts": [[2007, 1, 2]]}, "references-count": 6, "journal-issue": {"issue": "11"}, "URL": "http://dx.doi.org/10.1111/j.1651-2227.2002.tb00142.x", "relation": {"cites": []}, "ISSN": ["0803-5253"], "issn-type": [{"value": "0803-5253", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T04:32:47Z", "timestamp": 1574829167650}, "reference-count": 16, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Nuclear Medicine"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1097/rlu.0000000000001820", "type": "journal-article", "created": {"date-parts": [[2017, 9, 1]], "date-time": "2017-09-01T20:38:25Z", "timestamp": 1504298305000}, "page": "912-917", "source": "Crossref", "is-referenced-by-count": 17, "title": ["89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2\u2013Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2\u2013Negative Primary Breast Cancer"], "prefix": "10.1097", "volume": "42", "author": [{"given": "Gary A.", "family": "Ulaner", "sequence": "first", "affiliation": []}, {"given": "David M.", "family": "Hyman", "sequence": "additional", "affiliation": []}, {"given": "Serge K.", "family": "Lyashchenko", "sequence": "additional", "affiliation": []}, {"given": "Jason S.", "family": "Lewis", "sequence": "additional", "affiliation": []}, {"given": "Jorge A.", "family": "Carrasquillo", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Clinical Nuclear Medicine"], "language": "en", "link": [{"URL": "http://Insights.ovid.com/crossref?an=00003072-201712000-00002", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 3]], "date-time": "2017-11-03T18:13:01Z", "timestamp": 1509732781000}, "score": 25.547422, "subtitle": [""], "issued": {"date-parts": [[2017, 12]]}, "references-count": 16, "journal-issue": {"issue": "12"}, "URL": "http://dx.doi.org/10.1097/rlu.0000000000001820", "ISSN": ["0363-9762"], "issn-type": [{"value": "0363-9762", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:03:19Z", "timestamp": 1574132599690}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 11, 1]], "date-time": "1988-11-01T00:00:00Z", "timestamp": 594345600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2015, 12, 2]], "date-time": "2015-12-02T00:00:00Z", "timestamp": 1449014400000}, "delay-in-days": 9892, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Investigative Dermatology"], "published-print": {"date-parts": [[1988, 11]]}, "DOI": "10.1111/1523-1747.ep12476480", "type": "journal-article", "created": {"date-parts": [[2004, 7, 19]], "date-time": "2004-07-19T21:27:52Z", "timestamp": 1090272472000}, "page": "440-445", "source": "Crossref", "is-referenced-by-count": 109, "title": ["Stimulatory Effects of Transforming Growth Factor-beta and Epidermal Growth Factor on Epidermal Cell Outgrowth from Porcine Skin Explant Cultures"], "prefix": "10.1016", "volume": "91", "author": [{"given": "Patricia A.", "family": "Hebda", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Investigative Dermatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022202X88900590?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022202X88900590?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 5]], "date-time": "2019-02-05T20:24:11Z", "timestamp": 1549398251000}, "score": 25.544369, "issued": {"date-parts": [[1988, 11]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[1988, 11]]}, "issue": "5"}, "alternative-id": ["S0022202X88900590"], "URL": "http://dx.doi.org/10.1111/1523-1747.ep12476480", "ISSN": ["0022-202X"], "issn-type": [{"value": "0022-202X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:47:03Z", "timestamp": 1574124423895}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 4, 1]], "date-time": "1994-04-01T00:00:00Z", "timestamp": 765158400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[1994, 4]]}, "DOI": "10.1016/0270-9139(94)90353-0", "type": "journal-article", "created": {"date-parts": [[2004, 4, 30]], "date-time": "2004-04-30T10:03:32Z", "timestamp": 1083319412000}, "page": "I46", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Transforming growth factor \u03b1 and epidermal growth factor receptor in experimental hepatocarcinogenesis"], "prefix": "10.1016", "volume": "19", "author": [{"given": "A", "family": "Burr", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0270-9139(94)90353-0?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0270-9139(94)90353-0?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T22:26:08Z", "timestamp": 1549751168000}, "score": 25.49825, "issued": {"date-parts": [[1994, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 4]]}, "issue": "4"}, "alternative-id": ["0270-9139(94)90353-0"], "URL": "http://dx.doi.org/10.1016/0270-9139(94)90353-0", "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:19:41Z", "timestamp": 1574327981005}, "reference-count": 6, "publisher": "Oxford University Press (OUP)", "issue": "21", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JNCI Journal of the National Cancer Institute"], "published-print": {"date-parts": [[2007, 11, 7]]}, "DOI": "10.1093/jnci/djm177", "type": "journal-article", "created": {"date-parts": [[2007, 10, 31]], "date-time": "2007-10-31T03:51:43Z", "timestamp": 1193802703000}, "page": "1644-1645", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Responses: Re: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy"], "prefix": "10.1093", "volume": "99", "author": [{"given": "U.", "family": "Veronesi", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Bonanni", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Decensi", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2007, 10, 30]]}, "reference": [{"issue": "9", "key": "1_28401490", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1093/jnci/djk154", "volume": "99", "author": "Veronesi", "year": "2007", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "4", "key": "2_23631240", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1093/jnci/djk049", "volume": "99", "author": "Cuzick", "year": "2007", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "4", "key": "3_23631241", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1093/jnci/djk050", "volume": "99", "author": "Powles", "year": "2007", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"key": "4_17755655", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1007/978-3-642-55647-0_10", "volume": "163", "author": "Decensi", "year": "2003", "journal-title": "Recent results in cancer research. Fortschritte der Krebsforschung. Progr&#x00A0;&#x00A0;s dans les recherches sur le cancer", "ISSN": "http://id.crossref.org/issn/0080-0015", "issn-type": "print"}, {"issue": "27", "key": "6_29263080", "doi-asserted-by": "publisher", "first-page": "4201", "DOI": "10.1200/JCO.2006.09.4318", "volume": "25", "year": "2007", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "9382", "key": "7_17775378", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1016/S0140-6736(03)14066-4", "volume": "362", "author": "Scarabin", "year": "2003", "journal-title": "Lancet", "ISSN": "http://id.crossref.org/issn/0140-6736", "issn-type": "print"}], "container-title": ["JNCI Journal of the National Cancer Institute"], "language": "en", "link": [{"URL": "http://academic.oup.com/jnci/article-pdf/99/21/1644/7688893/djm177.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T17:12:19Z", "timestamp": 1503508339000}, "score": 25.495281, "issued": {"date-parts": [[2007, 10, 30]]}, "references-count": 6, "journal-issue": {"published-online": {"date-parts": [[2007, 11, 6]]}, "published-print": {"date-parts": [[2007, 11, 7]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1093/jnci/djm177", "relation": {"cites": []}, "ISSN": ["0027-8874", "1460-2105"], "issn-type": [{"value": "0027-8874", "type": "print"}, {"value": "1460-2105", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}